11. No morir de cáncer de mama

 

[1]. American Cancer Society, «Breast Cancer Facts & Figures 2013–2014», en <http://www.cancer.org/acs/groups/content/@research/documents/document/acspc-042725.pdf>, 2013. Último acceso 10 de marzo de 2015.

[2]. Sanders, M. E., Schuyler, P. A., Dupont, W. D., Page, D. L., «The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of longterm follow-up», en Cancer, 103(12), 2005, pp. 2481–2484.

[3]. Nielsen, M., Thomsen, J. L., Primdahl, S., Dyreborg, U., Andersen, J. A., «Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies», en Br J Cancer, 56(6), 1987, pp. 814–819.

[4]. Soto, A. M., Brisken, C., Schaeberle, C., Sonnenschein, C., «Does cancer start in the womb? Altered mammary gland development and predisposition to breast cancer due to in utero exposure to endocrine disruptors», en J Mammary Gland Biol Neoplasia, 18(2), 2013, pp. 199–208.

[5]. Del Monte, U., «Does the cell number 10(9) still really fit one gram of tumor tissue?», en Cell Cycle, 8(3), 2009, pp. 505–506.

[6]. Black, W. C., Welch, H. G., «Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy», en N Engl J Med., 328(17), 1993, pp. 1237–1243.

[7]. Friberg, S., Mattson, S., «On the growth rates of human malignant tumors: implications for medical decision making», en J Surg Oncol., 65(4), 1997, pp. 284–297.

[8]. Philippe, E., Le Gal, Y., «Growth of seventy-eight recurrent mammary cancers. Quantitative study», en Cancer, 21(3), 1968, pp. 461–467.

[9]. Kuroishi, T., Tominaga, S., Morimoto, T., et al., «Tumor growth rate and prognosis of breast cancer mainly detected by mass screening», en Jpn J Cancer Res., 81(5), 1990, pp. 454–462.

[10]. American Association for Cancer Research, «Studies weigh cost, effectiveness of mammography», en Cancer Discov., 4(5), 2014, p. OF5.

[11]. Nielsen, M., Thomsen, J. L., Primdahl, S., Dyreborg, U., Andersen, J. A., «Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies», en Br J Cancer, 56(6), 1987, pp. 814–819.

[12]. American Institute for Cancer Research, «Recommendations for Cancer Prevention», en <http://www.aicr.org/reduce-your-cancer-risk/recommendations-for-cancer-prevention/)>, 12 de septiembre de 2014. Último acceso 10 de marzo de 2015.

[13]. American Institute for Cancer Research, «AICR, the China Study, and Forks Over Knives», en <http://www.aicr.org/about/advocacy/the-china-study.html>, 9 de enero de 2015. Último acceso 10 de marzo de 2015.

[14]. Hastert, T. A., Beresford, S. A. A., Patterson, R. E., Kristal, A. R., White, E., «Adherence to WCRF/AICR cancer prevention recommendations and risk of postmenopausal breast cancer», en Cancer Epidemiol Biomarkers Prev., 22(9), 2013, pp. 1498–1508.

[15]. Barnard, R. J., Gonzalez, J. H., Liva, M. E., Ngo, T. H., «Effects of a low-fat, high-fi ber diet and exercise program on breast cancer risk factors in vivo and tumor cell growth and apoptosis in vitro», en Nutr Cancer, 55(1), 2006, pp. 28–34.

[16]. Ngo, T. H., Barnard, R. J., Tymchuk, C. N., Cohen, P., Aronson, W. J., «Effect of diet and exercise on serum insulin, IGF-I, and IGFBP-1 levels and growth of LNCaP cells in vitro (United States)», en Cancer Causes Control, 13(10), 2002, pp. 929–935.

[17]. Allen, N. E., Appleby, P. N., Davey, G. K., Kaaks, R., Rinaldi, S., Key, T. J., «The associations of diet with serum insulin-like growth factor I and its main binding proteins in 292 women meat-eaters, vegetarians and vegans», en Cancer Epidemiol Biomarkers Prev., 11(11), 2002, pp. 1441–1448.

[18]. IARC, «IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol 96, Alcohol Consumption and Ethyl Carbamate», International Agency for Research on Cancer, Lion, Francia, 2010.

[19]. Stewart, B. W., Wild, C. P. (comps.), World Cancer Report 2014, International Agency for Research on Cancer, Lion, Francia, 2014.

[20]. Bagnardi, V., Rota, M., Botteri, E., et al., «Light alcohol drinking and cancer: a meta-analysis», en Ann Oncol., 24(2), 2013, pp. 301–308.

[21]. Linderborg, K., Salaspuro, M., Väkeväinen, S., «A single sip of a strong alcoholic beverage causes exposure to carcinogenic concentrations of acetaldehyde in the oral cavity», en Food Chem Toxicol., 49(9), 2011, pp. 2103–2106.

[22]. Lachenmeier, D. W., Gumbel-Mako, S., Sohnius, E. M., Keck-Wilhelm, A., Kratz, E., Mildau, G., «Salivary acetaldehyde increase due to alcohol-containing mouthwash use: a risk factor for oral cancer», en Int J Cancer, 125(3), 2009, pp. 730–735.

[23]. Chen, W. Y., Rosner, B., Hankinson, S. E., Colditz, G. A., Willett, W. C., «Moderate alcohol consumption during adult life, drinking patterns, and breast cancer risk», en JAMA, 306(17), 2011, pp. 1884–1890.

[24]. Shufelt, C., Merz, C. N., Yang, Y., et al., «Red versus white wine as a nutritional aromatase inhibitor in premenopausal women: a pilot study», en J Womens Health (Larchmt), 21(3), 2012, pp. 281–284.

[25]. Eng, E. T., Williams, D., Mandava, U., Kirma, N., Tekmal, R. R., Chen, S., «Anti-aromatase chemicals in red wine», en Ann N Y Acad Sci., 963, 2002, pp. 239–246.

[26]. Shufelt, C., Merz, C. N., Yang, Y., et al., «Red versus white wine as a nutritional aromatase inhibitor in premenopausal women: a pilot study», en J Womens Health (Larchmt), 21(3), 2012, pp. 281–284.

[27]. Chen, S., Sun, X. Z., Kao, Y. C., Kwon, A., Zhou, D., Eng, E., «Suppression of breast cancer cell growth with grape juice», en Pharmaceutical Biology, 36(Suppl 1), 1998, pp. 53–61.

[28]. Chen, S., Sun, X. Z., Kao, Y. C., Kwon, A., Zhou, D., Eng, E., «Suppression of breast cancer cell growth with grape juice», en Pharmaceutical Biology, 36(Suppl 1), 1998, pp. 53–61.

[29]. Adams, L. S., Zhang, Y., Seeram, N. P., Heber, D., Chen, S., «Pomegranate ellagitannin-derived compounds exhibit anti-proliferative and anti-aromatase activity in breast cancer cells in vitro», en Cancer Prev Res. (Filadelfia), 3(1), 2010, pp. 108–113.

[30]. Chen, S., Oh, S. R., Phung, S., et al., «Anti-aromatase activity of phytochemicals in white button mushrooms (Agaricus bisporus)», en Cancer Res., 66(24), 2006, pp. 12026–12034.

[31]. Mishal, A. A., «Effects of different dress styles on vitamin D levels in healthy young Jordanian women», en Osteoporos Int., 12(11), 2001, pp. 931–935.

[32]. Cardinali, D. P., Pévet, P., «Basic aspects of melatonin action», en Sleep Med Rev., 2(3), 1998, pp. 175–190.

[33]. Blask, D. E., Dauchy, R. T., Sauer, L. A., «Putting cancer to sleep at night: the neuroendocrine/circadian melatonin signal», en Endocrine, 27(2), 2005, pp. 179–188.

[34]. Flynn-Evans, E. E., Stevens, R. G., Tabandeh, H., Schernhammer, E. S., Lockley, S. W., «Total visual blindness is protective against breast cancer», en Cancer Causes Control, 20(9), 2009, pp. 1753–1756.

[35]. He, C., Anand, S. T., Ebell, M. H., Vena, J. E., Robb, S. W., «Circadian disrupting exposures and breast cancer risk: a meta-analysis», en Int Arch Occup Environ Health, 88(5), julio de 2015, pp. 533–547.

[36]. Hurley, S., Goldberg, D., Nelson, D., et al., «Light at night and breast cancer risk among California teachers», en Epidemiology, 25(5), 2014, pp. 697– 706.

[37]. Bauer, S. E., Wagner, S. E., Burch, J., Bayakly, R., Vena, J. E., «A case-referent study: light at night and breast cancer risk in Georgia», en Int J Health Geogr., 12, 2013, p. 23.

[38]. Kloog, I., Haim, A., Stevens, R. G., Barchana, M., Portnov, B. A., «Light at night co-distributes with incident breast but not lung cancer in the female population of Israel», en Chronobiol Int., 25(1), 2008, pp. 65–81.

[39]. Li, Q., Zheng, T., Holford, T. R., Boyle, P., Zhang, Y., Dai, M., «Light at night and breast cancer risk: results from a population-based case-control study in Connecticut, USA», en Cancer Causes Control, 21(12), 2010, pp. 2281–2285.

[40]. Basler, M., Jetter, A., Fink, D., Seifert, B., Kullak-Ublick, G. A., Trojan, A., «Urinary excretion of melatonin and association with breast cancer: meta-analysis and review of the literature», en Breast Care (Basel), 9(3), 2014, pp. 182–187.

[41]. Nagata, C., Nagao, Y., Shibuya, C., Kashiki, Y., Shimizu, H., «Association of vegetable intake with urinary 6-sulfatoxymelatonin level», en Cancer Epidemiol Biomarkers Prev., 14(5), 2005, 1333–1335.

[42]. Schernhammer, E. S., Feskanich, D., Niu, C., Dopfel, R., Holmes, M. D., Hankinson, S. E., «Dietary correlates of urinary 6-sulfatoxymelatonin concentrations in the Nurses' Health Study cohorts», en Am J Clin Nutr., 90(4), 2009, pp. 975–985.

[43]. Gonçalves, A. K., Dantas Florencio, G. L., Maisonnette de Atayde Silva, M. J., Cobucci, R. N., Giraldo, P. C., Cote, N. M., «Effects of physical activity on breast cancer prevention: a systematic review», en J Phys Act Health, 11(2), 2014, pp. 445–454.

[44]. Friedenreich, C. M., Woolcott, C. G., McTiernan, A., et al., «Alberta physical activity and breast cancer prevention trial: sex hormone changes in a year-long exercise intervention among postmenopausal women», en J Clin Oncol., 28(9), 2010, pp. 1458–1466.

[45]. Kossman, D. A., Williams, N. I., Domchek, S. M., Kurzer, M. S., Stopfer, J. E., Schmitz, K. H., «Exercise lowers estrogen and progesterone levels in premenopausal women at high risk of breast cancer», en J Appl Physiol., 111(6), 2011, pp. 1687–1693.

[46]. Thune, I., Furberg, A. S., «Physical activity and cancer risk: dose-response and cancer, all sites and site-specific», en Med Sci Sports Exerc., 33(6 Suppl), 2001, pp. S530–S550.

[47]. Carpenter, C. L., Ross, R. K., Paganini-Hill, A., Bernstein, L., «Lifetime exercise activity and breast cancer risk among post-menopausal women», en Br J Cancer, 80(11), 1999, pp. 1852–1858.

[48]. Peters, T. M., Moore, S. C., Gierach, G. L., et al., «Intensity and timing of physical activity in relation to postmenopausal breast cancer risk: the prospective NIH-AARP diet and health study», en BMC Cancer, 9, 2009, p. 349.

[49]. Friedenreich, C. M., Cust, A. E., «Physical activity and breast cancer risk: impact of timing, type and dose of activity and population subgroup effects», en Br J Sports Med., 42(8), 2008, pp. 636–647.

[50]. Hildebrand, J. S., Gapstur, S. M., Campbell, P. T., Gaudet, M. M., Patel, A. V., «Recreational physical activity and leisure-time sitting in relation to postmenopausal breast cancer risk», en Cancer Epidemiol Biomarkers Prev., 22(10), 2013, pp. 1906–1912.

[51]. Widmark, E. M. P., «Presence of cancer-producing substances in roasted food», en Nature, 143, 1939, p. 984.

[52]. National Cancer Institute, «Chemicals in Meat Cooked at High Temperatures and Cancer Risk», en <http://www.cancer.gov/cancertopics/factsheet/Risk/cooked-meats>. Revisado el 15 de octubre de 2010. Último acceso 10 de marzo de 2015.

[53]. Shaughnessy, D. T., Gangarosa, L. M., Schliebe, B., et al., «Inhibition of fried meat-induced colorectal DNA damage and altered systemic genotoxicity in humans by crucifera, chlorophyllin, and yogurt», en PLoS ONE, 6(4), 2011, p. e18707.

[54]. Zaidi, R., Kumar, S., Rawat, P. R., «Rapid detection and quantification of dietary mutagens in food using mass spectrometry and ultra performance liquid chromatography», en Food Chem., 135(4), 2012, pp. 2897–2903.

[55]. Thiébaud, H. P., Knize, M. G., Kuzmicky, P. A., Hsieh, D. P., Felton, J. S., «Airborne mutagens produced by frying beef, pork and a soy-based food», en Food Chem Toxicol., 33(10), 1995, pp. 821–828.

[56]. Zheng, W., Lee, S. A., «Well-done meat intake, heterocyclic amine exposure, and cancer risk», en Nutr Cancer, 61(4), 2009, pp. 437–446.

[57]. Goldfinger, S. E., «By the way, doctor. In your May issue you say that eating medium or well-done beef increases one's risk for stomach cancer. But what about the dangers of eating rare beef?», en Harv Health Lett., 24(5), 1999, p. 7.

[58]. Frandsen, H., Frederiksen, H., Alexander, J., «2-Amino-1-methyl-6-(5-hydroxy-)phenylimidazo[4,5-b]pyridine (5-OH-PhIP), a biomarker for the genotoxic dose of the heterocyclic amine, 2-amino-1methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)», en Food Chem Toxicol., 40(8), 2002, pp. 1125–1130.

[59]. Frandsen, H., «Biomonitoring of urinary metabolites of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) following human consumption of cooked chicken», en Food Chem Toxicol., 46(9), 2008, pp. 3200–3205.

[60]. Steck, S. E., Gaudet, M. M., Eng, S. M., et al., «Cooked meat and risk of breast cancer—lifetime versus recent dietary intake», en Epidemiology, 18(3), 2007, pp. 373–382.

[61]. Zheng, W., Gustafson, D. R., Sinha, R., et al., «Well-done meat intake and the risk of breast cancer», en J Natl Cancer Inst., 90(22), 1998, pp. 1724–1729.

[62]. Rohrmann, S., Lukas Jung, S. U., Linseisen, J., Pfau, W., «Dietary intake of meat and meat-derived heterocyclic aromatic amines and their correlation with DNA adducts in female breast tissue», en Mutagenesis, 24(2), 2009, pp. 127–132.

[63]. Santella, R. M., Gammon, M., Terry, M., et al., «DNA adducts, DNA repair genotype/phenotype and cancer risk», en Mutat Res., 592(1–2), 2005, pp. 29–35.

[64]. Lauber, S. N., Ali, S., Gooderham, N. J., «The cooked food derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine is a potent oestrogen: a mechanistic basis for its tissue-specific carcinogenicity», en Carcinogenesis, 25(12), 2004, pp. 2509–2517.

[65]. Debruin, L. S., Martos, P. A., Josephy, P. D., «Detection of PhIP (2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine) in the milk of healthy women», en Chem Res Toxicol., 14(11), 2001, pp. 1523–1528.

[66]. Lauber, S. N., Ali, S., Gooderham, N. J., «The cooked food derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine is a potent oestrogen: a mechanistic basis for its tissue-specific carcinogenicity», en Carcinogenesis, 25(12), 2004, pp. 2509–2517.

[67]. Debruin, L. S., Martos, P. A., Josephy, P. D., «Detection of PhIP (2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine) in the milk of healthy women», en Chem Res Toxicol., 14(11), 2001, pp. 1523–1528.

[68]. Bessette, E. E., Yasa, I., Dunbar, D., Wilkens, L. R., Le Marchand, L., Turesky, R. J., «Biomonitoring of carcinogenic heterocyclic aromatic amines in hair: a validation study», en Chem Res Toxicol., 22(8), 2009, pp. 1454–1463.

[69]. Grose, K. R., Grant, J. L., Bjeldanes, L. F., et al., «Isolation of the carcinogen IQ from fried egg patties», en J Agric Food Chem., 34(2), 1986, pp. 201–202.

[70]. Holland, R. D., Gehring, T., Taylor, J., Lake, B. G., Gooderham, N. J., Turesky, R. J., «Formation of a mutagenic heterocyclic aromatic amine from creatinine in urine of meat eaters and vegetarians», en Chem Res Toxicol., 18(3), 2005, pp. 579–590.

[71]. Magagnotti, C., Orsi, F., Bagnati, R., et al., «Effect of diet on serum albumin and hemoglobin adducts of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in humans», en Int J Cancer, 88(1), 2000, pp. 1–6.

[72]. Lauber, S. N., Gooderham, N. J., «The cooked meat-derived mammary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5- b]pyridine promotes invasive behaviour of breast cancer cells», en Toxicology, 279(1–3), 2011, pp. 139–145.

[73]. Lauber, S. N., Gooderham, N. J., «The cooked meat-derived mammary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5- b]pyridine promotes invasive behaviour of breast cancer cells», en Toxicology, 279(1–3), 2011, pp. 139–145.

[74]. Vergnaud, A. C., Romaguera, D., Peeters, P. H., et al., «Adherence to the World Cancer Research Fund/American Institute for Cancer Research guidelines and risk of death in Europe: results from the European Prospective Investigation into Nutrition and Cancer cohort study», en Am J Clin Nutr., 97(5), 2013, pp. 1107–1120.

[75]. Danilo, C., Frank, P. G., «Cholesterol and breast cancer development», en Current Opinion in Pharmacology, 12(6), 2012, p. 677.

[76]. Firestone, R. A., «Low-density lipoprotein as a vehicle for targeting antitumor compounds to cancer cells», en Bioconjug Chem., 5(2), 1994, pp. 105–113.

[77]. Rudling, M. J., Ståhle, L., Peterson, C. O., Skoog, L., «Content of low density lipoprotein receptors in breast cancer tissue related to survival of patients», en Br Med J (Clin Res Ed), 292(6520), 1986, pp. 580–582.

[78]. Danilo, C., Frank, P.G., «Cholesterol and breast cancer development», en Current Opinion in Pharmacology, 12(6), 2012, pp. 677–682.

[79]. Antalis, C. J., Arnold, T., Rasool, T., Lee, B., Buhman, K. K., Siddiqui, R. A., «High ACAT1 expression in estrogen receptor negative basal-like breast cancer cells is associated with LDL-induced proliferation», en Breast Cancer Res Treat., 122(3), 2010, pp. 661–670.

[80]. Firestone, R. A., «Low-density lipoprotein as a vehicle for targeting antitumor compounds to cancer cells», en Bioconjug Chem., 5(2), 1994, pp. 105–113.

[81]. Kitahara, C. M., Berrington de González, A., Freedman, N. D., et al., «Total cholesterol and cancer risk in a large prospective study in Korea», en J Clin Oncol., 29(12), 2011, pp. 1592–1598.

[82]. Undela, K., Srikanth, V., Bansal, D., «Statin use and risk of breast cancer: a meta-analysis of observational studies», en Breast Cancer Res Treat., 135(1), 2012, pp. 261–269.

[83]. McDougall, J. A., Malone, K. E., Daling, J. R., Cushing-Haugen, K. L., Porter, P. L., Li, C. I., «Long-term statin use and risk of ductal and lobular breast cancer among women 55 to 74 years of age», en Cancer Epidemiol Biomarkers Prev., 22(9), 2013, pp. 1529–1537.

[84]. Centers for Disease Control and Prevention, «Data table for Figure 17. Statin drug use in the past 30 days among adults 45 years of age and over, by sex and age: United States, 1988–1994, 1999–2002, and 2005–2008. National Health and Nutrition Examination Survey. Chartbook: Centers for Disease Control; 2010», en <http://www.cdc.gov/nchs/data/hus/2010/fig17.pdf>. Último acceso 25 de marzo de 2015.

[85]. Maunsell, E., Drolet, M., Brisson, J., Robert, J., Deschell, L., «Dietary change after breast cancer: extent, predictors, and relation with psychological distress», en J Clin Oncol., 20(4), 2002, pp. 1017–1025.

[86]. Pierce, J. P., Stefanick, M. L., Flatt, S. W., et al., «Greater survival after breast cancer in physically active women with high vegetable-fruit intake regardless of obesity», en J Clin Oncol., 25(17), 2007, pp. 2345–2351.

[87]. Li, Q., Holford, T. R., Zhang, Y., et al., «Dietary fiber intake and risk of breast cancer by menopausal and estrogen receptor status», en Eur J Nutr., 52(1), 2013, pp. 217–223.

[88]. Li, Q., Holford, T. R., Zhang, Y., et al., «Dietary fiber intake and risk of breast cancer by menopausal and estrogen receptor status», en Eur J Nutr., 52(1), 2013, pp. 217–223.

[89]. Howe, G. R., Hirohata, T., Hislop, T. G., et al., «Dietary factors and risk of breast cancer: combined analysis of 12 case-control studies», en J Natl Cancer Inst., 82(7), 1990, pp. 561–569.

[90]. Dong, J.-Y., He, K., Wang, P., Qin, L. Q., «Dietary fiber intake and risk of breast cancer: a meta-analysis of prospective cohort studies», en Am J Clin Nutr., 94(3), 2011, pp. 900–905.

[91]. Aune, D., Chan, D. S., Greenwood, D. C., et al., «Dietary fiber and breast cancer risk: a systematic review and meta-analysis of prospective studies», en Ann Oncol., 23(6), 2012, pp. 1394–1402.

[92]. Clemens, R., Kranz, S., Mobley, A. R., et al., «Filling America's fiber intake gap: summary of a roundtable to probe realistic solutions with a focus on grain-based foods», en J Nutr., 142(7), 2012, pp. 1390S–1401S.

[93]. Farmer, B., Larson, B. T., Fulgoni, V. L., Rainville, A. J., Liepa, G. U., «A vegetarian dietary pattern as a nutrient-dense approach to weight management: an analysis of the National Health and Nutrition Examination Survey 1999–2004», en J Am Diet Assoc., 111(6), 2011, pp. 819–827.

[94]. Rizzo, N. S., Jaceldo-Siegl, K., Sabate, J., Fraser, G. E., «Nutrient profiles of vegetarian and nonvegetarian dietary patterns», en J Acad Nutr Diet., 113(12), 2013, pp. 1610–1619.

[95]. Dewell, A., Weidner, G., Sumner, M. D., Chi, C. S., Ornish, D., «A very-low-fat vegan diet increases intake of protective dietary factors and decreases intake of pathogenic dietary factors», en J Am Diet Assoc., 108(2), 2008, pp. 347–356.

[96]. Gallus, S., Talamini, R., Giacosa, A., et al., «Does an apple a day keep the oncologist away?», en Ann Oncol., 16(11), 2005, pp. 1841–1844.

[97]. Wolfe, K., Wu, X., Liu, R. H., «Antioxidant activity of apple peels», en J Agric Food Chem., 51(3), 2003, pp. 609–614.

[98]. Sun, J., Liu, R. H., «Apple phytochemical extracts inhibit proliferation of estrogen-dependent and estrogen-independent human breast cancer cells through cell cycle modulation», en J Agric Food Chem., 56(24), 2008, pp. 11661–11667.

[99]. Wolfe, K., Wu, X., Liu, R. H., «Antioxidant activity of apple peels», en J Agric Food Chem., 51(3), 2003, pp. 609–614.

[100]. Reagan-Shaw, S., Eggert, D., Mukhtar, H., Ahmad, N., «Antiproliferative effects of apple peel extract against cancer cells», en Nutr Cancer, 62(4), 2010, pp. 517–524.

[101]. Steck, S. E., Gaudet, M. M., Eng, S. M., et al., «Cooked meat and risk of breast cancer—lifetime versus recent dietary intake», en Epidemiology, 18(3), 2007, pp. 373–382.

[102]. Murray, S., Lake, B. G., Gray, S., et al., «Effect of cruciferous vegetable consumption on heterocyclic aromatic amine metabolism in man», en Carcinogenesis, 22(9), 2001, pp. 1413–1420.

[103]. Murray, S., Lake, B. G., Gray, S., et al., «Effect of cruciferous vegetable consumption on heterocyclic aromatic amine metabolism in man», en Carcinogenesis, 22(9), 2001, pp. 1413–1420.

[104]. Murray, S., Lake, B. G., Gray, S., et al., «Effect of cruciferous vegetable consumption on heterocyclic aromatic amine metabolism in man», en Carcinogenesis, 22(9), 2001, pp. 1413–1420.

[105]. Thiébaud, H. P., Knize, M. G., Kuzmicky, P. A., Hsieh, D. P., Felton, J. S., «Airborne mutagens produced by frying beef, pork and a soy-based food», en Food Chem Toxicol., 33(10), 1995, pp. 821–828.

[106]. Boggs, D. A., Palmer, J. R., Wise, L. A., et al., «Fruit and vegetable intake in relation to risk of breast cancer in the Black Women's Health Study», en Am J Epidemiol., 172(11), 2010, pp. 1268–1279.

[107]. Boggs, D. A., Palmer, J. R., Wise, L. A., et al., «Fruit and vegetable intake in relation to risk of breast cancer in the Black Women's Health Study», en Am J Epidemiol., 172(11), 2010, pp. 1268–1279.

[108]. Tiede, B., Kang, Y., «From milk to malignancy: the role of mammary stem cells in development, pregnancy and breast cancer», en Cell Res., 21(2), 2011, pp. 245–257.

[109]. Clevers, H., «The cancer stem cell: premises, promises and challenges», en Nat Med., 17(3), 2011, pp. 313–319.

[110]. Karrison, T. G., Ferguson, D. J., Meier, P., «Dormancy of mammary carcinoma after mastectomy», en J Natl Cancer Inst., 91(1), 1999, pp. 80–85.

[111]. Aguirre-Ghiso, J. A., «Models, mechanisms and clinical evidence for cancer dormancy», en Nat Rev Cancer, 7(11), 2007, pp. 834–846.

[112]. Clevers, H., «The cancer stem cell: premises, promises and challenges», en Nat Med., 17(3), 2011, pp. 313–319.

[113]. Li, Y., Zhang, T., Korkaya, H., et al., «Sulforaphane, a dietary component of broccoli/broccoli sprouts, inhibits breast cancer stem cells», en Clin Cancer Res., 16(9), 2010, pp. 2580–2590.

[114]. Cornblatt, B. S., Ye, L., Dinkova-Kostova, A. T., et al., «Preclinical and clinical evaluation of sulforaphane for chemoprevention in the breast», en Carcinogenesis, 28(7), 2007, pp. 1485–1490.

[115]. Fahey, J. W., Zhang, Y., Talalay, P., «Broccoli sprouts: an exceptionally rich source of inducers of enzymes that protect against chemical carcinogens», en Proc Natl Acad Sci USA, 94(19), 1997, pp. 10367–10372.

[116]. Goyal, A., Sharma, V., Upadhyay, N., Gill, S., Sihag, M., «Flax and flaxseed oil: an ancient medicine & modern functional food», en J Food Sci Technol., 51(9), 2014, pp. 1633–1653.

[117]. Smeds, A. I., Eklund, P. C., Sjöholm, R. E., et al., «Quantification of a broad spectrum of lignans in cereals, oilseeds, and nuts», en J Agric Food Chem., 55(4), 2007, pp. 1337–1346.

[118]. Rosolowich, V., Saettler, E., Szuck, B., et al., «Mastalgia», en J Obstet Gynaecol Can., 170, 2006, pp. 49–57.

[119]. Phipps, W. R., Martini, M. C., Lampe, J. W., Slavin, J. L., Kurzer, M. S., «Effect of flax seed ingestion on the menstrual cycle», en J Clin Endocrinol Metab., 77(5), 1993, pp. 1215–1219.

[120]. Kelsey, J. L., Gammon, M. D., John, E. M., «Reproductive factors and breast cancer», en Epidemiol Rev., 15(1), 1993, pp. 36–47.

[121]. Knekt, P., Adlercreutz, H., Rissanen, H., Aromaa, A., Teppo, L., Heliövaara, M., «Does antibacterial treatment for urinary tract infection contribute to the risk of breast cancer?», en Br J Cancer, 82(5), 2000, pp. 1107–1110.

[122]. Buck, K., Zaineddin, A. K., Vrieling, A., Linseisen, J., Chang-Claude, J., «Meta-analyses of lignans and enterolignans in relation to breast cancer risk», en Am J Clin Nutr., 92(1), 2010, pp. 141–153.

[123]. Abarzua, S., Serikawa, T., Szewczyk, M., Richter, D. U., Piechulla, B., Briese, V., «Antiproliferative activity of lignans against the breast carcinoma cell lines MCF 7 and BT 20», en Arch Gynecol Obstet., 285(4), 2012, pp. 1145–1151.

[124]. Fabian, C. J., Kimler, B. F., Zalles, C. M., et al., «Reduction in Ki-67 in benign breast tissue of high-risk women with the lignan secoisolariciresinol diglycoside», en Cancer Prev Res. (Filadelfia), 3(10), 2010, pp. 1342–1350.

[125]. Buck, K., Vrieling, A., Zaineddin, A. K., et al., «Serum enterolactone and prognosis of postmenopausal breast cancer», en J Clin Oncol., 29(28), 2011, pp. 3730–3738.

[126]. Guglielmini, P., Rubagotti, A., Boccardo, F., «Serum enterolactone levels and mortality outcome in women with early breast cancer: a retrospective cohort study», en Breast Cancer Res Treat., 132(2), 2012, pp. 661–668.

[127]. McCann, S. E., Thompson, L. U., Nie, J., et al., «Dietary lignan intakes in relation to survival among women with breast cancer: the Western New York Exposures and Breast Cancer (WEB) Study», en Breast Cancer Res Treat., 122(1), 2010, pp. 229–235.

[128]. Åberg, U. W., Saarinen, N., Abrahamsson, A., Nurmi, T., Engblom, S., Dabrosin, C., «Tamoxifen and flaxseed alter angiogenesis regulators in normal human breast tissue in vivo», en PLoS ONE, 6(9), 2011, p. e25720.

[129]. Thompson, L. U., Chen, J. M., Li, T., Strasser-Weippl, K., Goss, P. E., «Dietary flaxseed alters tumor biological markers in postmenopausal breast cancer», en Clin Cancer Res., 11(10), 2005, pp. 3828–3835.

[130]. Mueller, S. O., Simon, S., Chae, K., Metzler, M., Korach, K. S., «Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor alpha (ERalpha) and ERbeta in human cells», en Toxicol.Sci., 80(1), 2004, pp. 14–25.

[131]. Oseni, T., Patel, R., Pyle, J., Jordan, V. C., «Selective estrogen receptor modulators and phytoestrogens», en Planta Med., 74(13), 2008, pp. 1656–1665.

[132]. Oseni, T., Patel, R., Pyle, J., Jordan, V. C., «Selective estrogen receptor modulators and phytoestrogens», en Planta Med., 74(13), 2008, pp. 1656–1665.

[133]. Nagata, C., Mizoue, T., Tanaka, K., et al., «Soy intake and breast cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population», en Jpn J Clin Oncol., 44(3), 2014, pp. 282–295.

[134]. Chen, M. N., Lin, C. C., Liu, C. F., «Efficacy of phytoestrogens for menopausal symptoms: a metaanalysis and systematic review», en Climacteric., 18(2), 2015, pp. 260–269.

[135]. Chi, F., Wu, R., Zeng, Y. C., Xing, R., Liu, Y., Xu, Z. G., «Post-diagnosis soy food intake and breast cancer survival: a meta-analysis of cohort studies», en Asian Pac J Cancer Prev., 14(4), 2013, pp. 2407–2412.

[136]. Bhagwat, S., Haytowitz, D. B., Holden, J. M., «USDA Database for the Isofl avone Content of Selected Foods, Release 2.0», en <http://www.ars.usda.gov/SP2UserFiles/Place/12354500/Data/isoflav/Isoflav_R2.pdf>, septiembre de 2008. Último acceso 26 de marzo de 2015.

[137]. Nechuta, S. J., Caan, B. J., Chen, W. Y., et al., «Soy food intake after diagnosis of breast cancer and survival: an in-depth analysis of combined evidence from cohort studies of US and Chinese women», en Am J Clin Nutr., 96(1), 2012, pp. 123–132.

[138]. Chi, F., Wu, R., Zeng, Y. C., Xing, R., Liu, Y., Xu, Z. G., «Post-diagnosis soy food intake and breast cancer survival: a meta-analysis of cohort studies», en Asian Pac J Cancer Prev., 14(4), 2013, pp. 2407–2412.

[139]. Kang, H. B., Zhang, Y. F., Yang, J. D., Lu, K. L., «Study on soy isoflavone consumption and risk of breast cancer and survival», en Asian Pac J Cancer Prev., 13(3), 2012, pp. 995–998.

[140]. Bosviel, R., Dumollard, E., Déchelotte, P., Bignon, Y. J., Bernard-Gallon, D., «Can soy phytoestrogens decrease DNA methylation in BRCA1 and BRCA2 oncosuppressor genes in breast cancer?», en OMICS, 16(5), 2012, pp. 235–244.

[141]. National Breast Cancer Coalition, «National Breast Cancer Coalition survey reveals that heightened breast cancer awareness has insufficient impact on knowledge», en <http://www.prnewswire.com/news-releases/national-breast-cancer-coalition-survey-reveals-thatheightened-breast-cancer-awareness-has-insufficient-impact-on-knowledge-58248962.html>, 1 de octubre de 2007. Último acceso 23 de marzo de 2015.

[142]. Colditz, G. A., Willett, W. C., Hunter, D. J., et al., «Family history, age, and risk of breast cancer. Prospective data from the Nurses' Health Study», en JAMA, 270(3), 1993, pp. 338–343.

[143]. Bal, A., Verma, S., Joshi, K., et al., «BRCA1-methylated sporadic breast cancers are BRCAlike in showing a basal phenotype and absence of ER expression», en Virchows Arch., 461(3), 2012, pp. 305–312.

[144]. Bosviel, R., Dumollard, E., Déchelotte, P., Bignon, Y. J., Bernard-Gallon, D., «Can soy phytoestrogens decrease DNA methylation in BRCA1 and BRCA2 oncosuppressor genes in breast cancer?», en OMICS, 16(5), 2012, pp. 235–244.

[145]. Magee, P. J., Rowland, I., «Soy products in the management of breast cancer», en Curr Opin Clin Nutr Metab Care, 15(6), 2012, pp. 586–591.

[146]. Parkin, D. M., Fernández, L. M., «Use of statistics to assess the global burden of breast cancer», en Breast J., 12 Suppl 1, 2006, pp. S70–S80.

[147]. Wu, A. H., Butler, L. M., «Green tea and breast cancer», en Mol Nutr Food Res., 55(6), 2011, pp. 921–930.

[148]. Korde, L. A., Wu, A. H., Fears, T., et al., «Childhood soy intake and breast cancer risk in Asian American women», en Cancer Epidemiol Biomarkers Prev., 18(4), 2009, pp. 1050–1059.

[149]. Wakchaure, G. C., «Chapter 3: Production and marketing of mushrooms: Global and national scenario», en Mushrooms, Singh, N., Cijay, B., Kamal, S., Wakchaure, G. C. (comps.), Cultivation, Marketing and Consumption, Himachal Pradesh-173213, India, Directorate of Mushroom Research, 2014, pp. 15–22.

[150]. Zhang, M., Huang, J., Xie, X., Holman, C. D., «Dietary intakes of mushrooms and green tea combine to reduce the risk of breast cancer in Chinese women», en Int J Cancer, 124(6), 2009, pp. 1404–1408.

[151]. Ganz, P. A., «A teachable moment for oncologists: cancer survivors, 10 million strong and growing!», en J Clin Oncol., 23(24), 2005, pp. 5458–5460.

[152]. Ganz, P. A., «A teachable moment for oncologists: cancer survivors, 10 million strong and growing!», en J Clin Oncol., 23(24), 2005, pp. 5458–5460.

 

 

12. No morir de depresión mayor

 

[1]. Centers for Disease Control and Prevention, «National Center for Health Statistics. Deaths: Final Data for 2013, table 18», en <http://www.cdc.gov/nchs/data/nvsr/nvsr64/nvsr64_02.pdf>. Último acceso 20 de marzo de 2015.

[2]. Sartorius, N., «The economic and social burden of depression», en J Clin Psychiatry, 62 Suppl 15, 2001, pp. 8–11.

[3]. «Preamble to the Constitution of the World Health Organization as adopted by the International Health Conference», Nueva York, 19-22 de junio de 1946, firmado el 22 de julio de 1946 por representantes de 61 estados (Archivos oficiales de la Organización Mundial de la Salud, n.º 2, p. 100) y con entrada en vigor el 7 de abril de 1948.

[4]. Kessler, R. C., Chiu, W. T., Demler, O., Merikangas, K. R., Walters, E. E., «Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication», en Arch Gen Psychiatry, 62(6), 2005, pp. 617–627.

[5]. Chida, Y., Steptoe, A., «Positive psychological well-being and mortality: a quantitative review of prospective observational studies», en Psychosom Med., 70(7), 2008, pp. 741–756.

[6]. Chida, Y., Steptoe, A., «Positive psychological well-being and mortality: a quantitative review of prospective observational studies», en Psychosom Med., 70(7), 2008, pp. 741–756.

[7]. Grant, N., Wardle, J., Steptoe, A., «The relationship between life satisfaction and health behavior: a cross-cultural analysis of young adults, en Int J Behav Med., 16(3), 2009, pp. 259–268.

[8]. Cohen, S., Doyle, W. J., Turner, R. B., Alper, C. M., Skoner, D. P., «Emotional style and susceptibility to the common cold», en Psychosom Med., 65(4), 2003, pp. 652–657.

[9]. Cohen, S., Alper, C. M., Doyle, W. J., Treanor, J. J., Turner, R. B., «Positive emotional style predicts resistance to illness after experimental exposure to rhinovirus or influenza A virus», en Psychosom Med., 68(6), 2006, pp. 809–815.

[10]. Beezhold, B. L., Johnston, C. S., Daigle, D. R., «Vegetarian diets are associated with healthy mood states: a cross-sectional study in Seventh Day Adventist adults», en Nutr J., 9, 2010, p. 26.

[11]. Beezhold, B. L., Johnston, C. S., Daigle, D. R., «Vegetarian diets are associated with healthy mood states: a cross-sectional study in Seventh Day Adventist adults», en Nutr J., 9, 2010, p. 26.

[12]. Knutsen, S. F., «Lifestyle and the use of health services», en Am J Clin Nutr., 59(5 Suppl), 1994, pp. 1171S–1175S.

[13]. Beezhold, B. L., Johnston, C. S., Daigle, D. R., «Vegetarian diets are associated with healthy mood states: a cross-sectional study in Seventh Day Adventist adults», en Nutr J., 9, 2010, p. 26.

[14]. Fisher, M., Levine, P. H., Weiner, B., et al., «The effect of vegetarian diets on plasma lipid and platelet levels», en Arch Intern Med., 146(6), 1986, pp. 1193–1197.

[15]. Institute of Medicine, Dietary Reference Intakes: The Essential Guide to Nutrient Requirements, National Academies Press, Washington, D. C., 2006.

[16]. Vaz, J. S., Kac, G., Nardi, A. E., Hibbeln, J. R., «Omega-6 fatty acids and greater likelihood of suicide risk and major depression in early pregnancy», en J Affect Disord., 152–154, 2014, pp. 76–82.

[17]. National Cancer Institute, «Table 4: Food Sources of Arachidonic Acid.» <http://appliedresearch.cancer. gov/diet/foodsources/fatty_acids/table4.html>. Modificado el 18 de octubre de 2013. Último acceso 11 de marzo de 2015.

[18]. Hirota, S., Adachi, N., Gomyo, T., Kawashima, H., Kiso, Y., Kawabata, T., «Low-dose arachidonic acid intake increases erythrocytes and plasma arachidonic acid in young women», en Prostaglandins Leukot Essent Fatty Acids, 83(2), 2010, pp. 83–88.

[19]. Beezhold, B. L., Johnston, C. S., Daigle, D. R., «Vegetarian diets are associated with healthy mood states: a cross-sectional study in Seventh Day Adventist adults», en Nutr J., 9, 2010, p. 26.

[20]. Beezhold, B. L., Johnston, C. S., «Restriction of meat, fish, and poultry in omnivores improves mood: a pilot randomized controlled trial», en Nutr J., 11, 2012, p. 9.

[21]. Beezhold, B. L., Johnston, C. S., Daigle, D. R., «Restriction of flesh foods in omnivores improves mood: a pilot randomized controlled trial», en American Public Health Association Annual Conference, Filadelfia, PA, 7–11 de noviembre de 2009.

[22]. Katcher, H. I., Ferdowsian, H. R., Hoover, V. J., Cohen, J. L., Barnard, N. D., «A worksite vegan nutrition program is well-accepted and improves health-related quality of life and work productivity», en Ann Nutr Metab., 56(4), 2010, pp. 245–252.

[23]. Katcher, H. I., Ferdowsian, H. R., Hoover, V. J., Cohen, J. L., Barnard, N. D., «A worksite vegan nutrition program is well-accepted and improves health-related quality of life and work productivity», en Ann Nutr Metab., 56(4), 2010, pp. 245–252.

[24]. Mishra, S., Xu, J., Agarwal, U., Gonzales, J., Levin, S., Barnard, N. D., «A multicenter randomized controlled trial of a plant-based nutrition program to reduce body weight and cardiovascular risk in the corporate setting: the GEICO study», en Eur J Clin Nutr., 67(7), 2013, pp. 718–724.

[25]. Agarwal, U., Mishra, S., Xu, J., Levin, S., Gonzales, J., Barnard, N. D., «A multicenter randomized controlled trial of a nutrition intervention program in a multiethnic adult population in the corporate setting reduces depression and anxiety and improves quality of life: The GEICO Study», en Am J Health Promot., 29(4), 2015, pp. 245–254.

[26]. Tsai, A. C., Chang, T.-L., Chi, S.-H., «Frequent consumption of vegetables predicts lower risk of depression in older Taiwanese—results of a prospective population-based study», en Public Health Nutr., 15(6), 2012, pp. 1087–1092.

[27]. Gomez-Pinilla, F., Nguyen, T. T. J., «Natural mood foods: the actions of polyphenols against psychiatric and cognitive disorders», en Nutr Neurosci., 15(3), 2012, pp. 127–133.

[28]. Meyer, J. H., Ginovart, N., Boovariwala, A., et al., «Elevated monoamine oxidase A levels in the brain: an explanation for the monoamine imbalance of major depression», en Arch Gen Psychiatry, 63(11), 2006, pp. 1209–1216.

[29]. De Villiers, J. C., «Intracranial haemorrhage in patients treated with monoamineoxidase inhibitors», en Br J Psychiatry., 112(483), 1966, pp. 109–118.

[30]. Dixon Clarke, S. E., Ramsay, R. R., «Dietary inhibitors of monoamine oxidase A», en J Neural Transm., 118(7), 2011, pp. 1031–1041.

[31]. Lai, J. S., Hiles, S., Bisquera, A., Hure, A. J., McEvoy, M., Attia, J., «A systematic review and meta-analysis of dietary patterns and depression in community-dwelling adults», en Am J Clin Nutr., 99(1), 2014, pp. 181–197.

[32]. White, B. A., Horwath, C. C., Conner, T. S., «Many apples a day keep the blues away—daily experiences of negative and positive affect and food consumption in young adults», en Br J Health Psychol., 18(4), 2013, pp. 782–798.

[33]. Odjakova, M., Hadjiivanova, C., «Animal neurotransmitter substances in plants», en Bulg J Plant Physiol., 23, 1997, pp. 94–102.

[34]. Ghirri, A., Cannella, C., Bignetti, E., «The psychoactive effects of aromatic amino acids», en Curr Nutr Food Science, 7(1), 2011, pp. 21–32.

[35]. Allen, J. A., Peterson, A., Sufit, R., et al., «Post-epidemic eosinophilia-myalgia syndrome associated with L-tryptophan», en Arthritis Rheum., 63(11), 2011, pp. 3633–3639.

[36]. Fernstrom, J. D., Faller, D. V., «Neutral amino acids in the brain: changes in response to food ingestion», en J Neurochem., 30(6), 1978, pp. 1531–1538.

[37]. Wurtman, R. J., Wurtman, J. J., Regan, M. M., McDermott, J. M., Tsay, R. H., Breu, J. J., «Effects of normal meals rich in carbohydrates or proteins on plasma tryptophan and tyrosine ratios», en Am J Clin Nutr., 77(1), 2003, pp. 128–132.

[38]. Wurtman, J. J., Brzezinski, A., Wurtman, R. J., Laferrere, B., «Effect of nutrient intake on premenstrual depression», en Am J Obstet Gynecol., 161(5), 1989, pp. 1228–1234.

[39]. Brinkworth, G. D., Buckley, J. D., Noakes, M., Clifton, P. M., Wilson, C. J., «Long-term effects of a very low-carbohydrate diet and a low-fat diet on mood and cognitive function», en Arch Intern Med., 169(20), 2009, pp. 1873–1880.

[40]. Fernstrom, J. D., Wurtman, R. J., «Brain serotonin content: physiological regulation by plasma neutral amino acids», en Science, 178(4059), 1972, pp. 414–416.

[41]. Hudson, C., Hudson, S., MacKenzie, J., «Protein-source tryptophan as an efficacious treatment for social anxiety disorder: a pilot study», en Can J Physiol Pharmacol., 85(9), 2007, pp. 928–932.

[42]. Schweiger, U., Laessle, R., Kittl, S., Dickhaut, B., Schweiger, M., Pirke, K. M., «Macronutrient intake, plasma large neutral amino acids and mood during weight-reducing diets», en J Neural Transm., 67(1–2), 1986, pp. 77–86.

[43]. Ferrence, S. C., Bendersky, G., «Therapy with saffron and the goddess at Thera», en Perspect Biol Med., 47(2), 2004, pp. 199–226.

[44]. Noorbala, A. A., Akhondzadeh, S., Tahmacebi-Pour, N., Jamshidi, A. H., «Hydro-alcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a doubleblind, randomized pilot trial», en J Ethnopharmacol., 97(2), 2005, pp. 281–284.

[45]. Gohari, A. R., Saeidnia, S., Mahmoodabadi, M. K., «An overview on saffron, phytochemicals, and medicinal properties», en Pharmacogn Rev., 7(13), 2013, pp. 61–66.

[46]. Fukui, H., Toyoshima, K., Komaki, R., «Psychological and neuroendocrinological effects of odor of saffron (Crocus sativus)», en Phytomedicine, 18(8–9), 2011, pp. 726–730.

[47]. Lucas, M., O'Reilly, E. J., Pan, A., et al., «Coffee, caffeine, and risk of completed suicide: results from three prospective cohorts of American adults», en World J Biol Psychiatry., 15(5), 2014, pp. 377–386.

[48]. Klatsky, A. L., Armstrong, M. A., Friedman, G. D., «Coffee, tea, and mortality», en Ann Epidemiol., 3(4), 1993, pp. 375–381.

[49]. Tanskanen, A., Tuomilehto, J., Viinamnen, H., Vartiainen, E., Lehtonen, J., Puska, P., «Heavy coffee drinking and the risk of suicide», en Eur J Epidemiol., 16(9), 2000, pp. 789–791.

[50]. Guo, X., Park, Y., Freedman, N. D., et al., «Sweetened beverages, coffee, and tea and depression risk among older US adults», en PLoS One, 9(4), 2014, p. e94715.

[51]. Maher, T. J., Wurtman, R. J., «Possible neurologic effects of aspartame, a widely used food additive», en Environ Health Perspect., 75, 1987, pp. 53–57.

[52]. Walton, R. G., Hudak, R., Green-Waite, R. J., «Adverse reactions to aspartame: double-blind challenge in patients from a vulnerable population», en Biol Psychiatry, 34(1–2), 1993, pp. 13–17.

[53]. Lindseth, G. N., Coolahan, S. E., Petros, T. V., Lindseth, P. D., «Neurobehavioral effects of aspartame consumption», en Res Nurs Health, 37(3), 2014, pp. 185–193.

[54]. U.S. Food and Drug Administration, «Aspartame: Commissioner's final decision», en Fed Reg., 46, 1981, pp. 38285–38308.

[55]. Lindseth, G. N., Coolahan, S. E., Petros, T. V., Lindseth, P. D., «Neurobehavioral effects of aspartame consumption», en Res Nurs Health, 37(3), 2014, pp. 185–193.

[56]. Whitehouse, C. R., Boullata, J., McCauley, L. A., «The potential toxicity of artificial sweeteners», en AAOHN J., 56(6), 2008, pp. 251–259.

[57]. Aspartame Information Center: Consumer Products, en la página web de Aspartame, <http://www.aspartame.org/about/consumer-products/#.VF_cyr74tSU>. Actualizado en 2015. Último acceso 11 de marzo de 2015.

[58]. Whitehouse, C. R., Boullata, J., McCauley, L. A., «The potential toxicity of artificial sweeteners», en AAOHN J., 56(6), 2008, pp. 251–259.

[59]. Yeung, R. R., «The acute effects of exercise on mood state», en J Psychosom Res., 40(2), 1996, pp. 123–141.

[60]. Goodwin, R. D., «Association between physical activity and mental disorders among adults in the United States», en Prev Med., 36(6), 2003, pp. 698–703.

[61]. Blumenthal, J. A., Babyak, M. A., Moore, K. A., et al., «Effects of exercise training on older patients with major depression», en Arch Intern Med., 159(19), 1999, pp. 2349–2356.

[62]. Blumenthal, J. A., Babyak, M. A., Doraiswamy, P. M., et al., «Exercise and pharmacotherapy in the treatment of major depressive disorder», en Psychosom Med., 69(7), 2007, pp. 587–596.

[63]. Pandya, C. D., Howell, K. R., Pillai, A., «Antioxidants as potential therapeutics for neuropsychiatric disorders», en Prog Neuropsychopharmacol Biol Psychiatry, 46, 2013, pp. 214–223.

[64]. Michel, T. M., Pulschen, D., Thome, J., «The role of oxidative stress in depressive disorders», en Curr Pharm Des., 18(36), 2012, pp. 5890–5899.

[65]. McMartin, S. E., Jacka, F. N., Colman, I., «The association between fruit and vegetable consumption and mental health disorders: evidence from five waves of a national survey of Canadians», en Prev Med., 56(3–4), 2013, pp. 225–230.

[66]. Beydoun, M. A., Beydoun, H. A., Boueiz, A., Shroff, M. R., Zonderman, A. B., «Antioxidant status and its association with elevated depressive symptoms among US adults: National Health and Nutrition Examination Surveys 2005–6», en Br J Nutr., 109(9), 2013, pp. 1714–1729.

[67]. Niu, K., Guo, H., Kakizaki, M., et al., «A tomato-rich diet is related to depressive symptoms among an elderly population aged 70 years and over: a population-based, cross-sectional analysis», en J Affect Disord., 144(1–2), 2013, pp. 165–170.

[68]. Payne, M. E., Steck, S. E., George, R. R., Steffens, D. C., «Fruit, vegetable, and antioxidant intakes are lower in older adults with depression», en J Acad Nutr Diet., 112(12), 2012, pp. 2022–2027.

[69]. Gilbody, S., Lightfoot, T., Sheldon, T., «Is low folate a risk factor for depression? A meta-analysis and exploration of heterogeneity», en J Epidemiol Community Health, 61(7), 2007, pp. 631–637.

[70]. Tolmunen, T., Hintikka, J., Ruusunen, A., et al., «Dietary folate and the risk of depression in Finnish middle-aged men. A prospective follow-up study», en Psychother Psychosom., 73(6), 2004, pp. 334–339.

[71]. Sharpley, A. L., Hockney, R., McPeake, L., Geddes, J. R., Cowen, P. J., «Folic acid supplementation for prevention of mood disorders in young people at familial risk: a randomised, double blind, placebo controlled trial», en J Affect Disord., 167, 2014, pp. 306–311.

[72]. Penn, E., Tracy, D. K., «The drugs don't work? Antidepressants and the current and future pharmacological management of depression», en Ther Adv Psychopharmacol., 2(5), 2012, pp. 179–188.

[73]. Turner, E. H., Matthews, A. M., Linardatos, E., Tell, R. A., Rosenthal, R., «Selective publication of antidepressant trials and its influence on apparent efficacy», en N Engl J Med., 358(3), 2008, pp. 252–260.

[74]. Kirsch, I., «Antidepressants and the placebo effect», en Z Psychol., 222(3), 2014, pp. 128–134.

[75]. Kirsch, I., «Antidepressants and the placebo response», en Epidemiol Psichiatr Soc., 18(4), 2009, pp. 318–322.

[76]. Spence, D., «Are antidepressants overprescribed? Yes», en BMJ, 346, 2013, p. f191.

[77]. Sugarman, M. A., Loree, A. M., Baltes, B. B., Grekin, E. R., Kirsch, I., «The efficacy of paroxetine and placebo in treating anxiety and depression: a meta-analysis of change on the Hamilton Rating Scales», en PLoS ONE, 9(8), 2014, p. e106337.

[78]. Kirsch, I., «Antidepressants and the placebo effect», en Z Psychol., 222(3), 2014, pp. 128–134.

[79]. Blease, C., «Deception as treatment: the case of depression», en J Med Ethics, 37(1), 2011, pp. 13–16.

[80]. Kirsch, I., «Antidepressants and the placebo effect», en Z Psychol., 222(3), 2014, pp. 128–134.

[81]. Kirsch, I., «Antidepressants and the placebo effect», en Z Psychol., 222(3), 2014, pp. 128–134.

 

 

13. No morir de cáncer de próstata

 

[1]. Jahn, J. L., Giovannucci, E. L., Stampfer, M. J., «The high prevalence of undiagnosed prostate cancer at autopsy: implications for epidemiology and treatment of prostate cancer in the Prostate-specific Antigen-era», en Int J Cancer, 29 de diciembre de 2014.

[2]. Draisma, G., Etzioni, R., Tsodikov, A., et al., «Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context», en J Natl Cancer Inst., 101(6), 2009, pp. 374–383.

[3]. Centers for Disease Control and Prevention, «Prostate Cancer Statistics», en <http://www.cdc.gov/cancer/prostate/statistics/index.htm>. Actualizado el 2 de septiembre de 2014. Último acceso 11 de marzo de 2015.

[4]. Maruyama, K., Oshima, T., Ohyama, K., «Exposure to exogenous estrogen through intake of commercial milk produced from pregnant cows», en Pediatr Int., 52(1), 2010, pp. 33–38.

[5]. Danby, F. W., «Acne and milk, the diet myth, and beyond», en J Am Acad Dermatol., 52(2), 2005, pp. 360–362.

[6]. Afeiche, M., Williams, P. L., Mendiola, J., et al., «Dairy food intake in relation to semen quality and reproductive hormone levels among physically active young men», en Hum Reprod., 28(8), 2013, pp. 2265–2275.

[7]. Maruyama, K., Oshima, T., Ohyama, K., «Exposure to exogenous estrogen through intake of commercial milk produced from pregnant cows», en Pediatr Int., 52(1), 2010, pp. 33–38.

[8]. Steinman, G., «Mechanisms of twinning: VII. Effect of diet and heredity on the human twinning rate», en J Reprod Med., 51(5), 2006, pp. 405–410.

[9]. Melnik, B. C., John, S. M., Schmitz, G., «Milk is not just food but most likely a genetic transfection system activating mTORC1 signaling for postnatal growth», en Nutr J., 12, 2013, p. 103.

[10]. Ludwig, D. S., Willett, W. C., «Three daily servings of reduced-fat milk: an evidence-based recommendation?», en JAMA Pediatr., 167(9), 2013, pp. 788–789.

[11]. Ludwig, D. S., Willett, W. C., «Three daily servings of reduced-fat milk: an evidence-based recommendation?», en JAMA Pediatr., 167(9), 2013, pp. 788–789.

[12]. Tate, P. L., Bibb, R., Larcom, L. L., «Milk stimulates growth of prostate cancer cells in culture», en Nutr Cancer, 63(8), 2011, pp. 1361–1366.

[13]. Ganmaa, D., Li, X. M., Qin, L. Q., Wang, P. Y., Takeda, M., Sato, A., «The experience of Japan as a clue to the etiology of testicular and prostatic cancers», en Med Hypotheses, 60(5), 2003, pp. 724–730.

[14]. Ganmaa, D., Li, X. M., Wang, J., Qin, L. Q., Wang, P. Y., Sato, A., «Incidence and mortality of testicular and prostatic cancers in relation to world dietary practices», en Int J Cancer, 98(2), 2002, pp. 262–267.

[15]. Epstein, S. S., «Unlabeled milk from cows treated with biosynthetic growth hormones: a case of regulatory abdication», en Int J Health Serv., 26(1), 1996, pp. 173–185.

[16]. Tate, P. L., Bibb, R., Larcom, L. L., «Milk stimulates growth of prostate cancer cells in culture», en Nutr Cancer, 63(8), 2011, pp. 1361–1366.

[17]. Qin, L. Q., Xu, J. Y., Wang, P. Y., Kaneko, T., Hoshi, K., Sato, A., «Milk consumption is a risk factor for prostate cancer: meta-analysis of case-control studies», en Nutr Cancer, 48(1), 2004, pp. 22–27.

[18]. Qin, L. Q., Xu, J. Y., Wang, P. Y., Tong, J., Hoshi, K., «Milk consumption is a risk factor for prostate cancer in Western countries: evidence from cohort studies», en Asia Pac J Clin Nutr., 16(3), 2007, pp. 467–476.

[19]. Aune, D., Navarro Rosenblatt, D. A., Chan, D. S., et al., «Dairy products, calcium, and prostate cancer risk: a systematic review and meta-analysis of cohort studies», en Am J Clin Nutr., 101(1), 2015, pp. 87–117.

[20]. Bischoff-Ferrari, H. A., Dawson-Hughes, B., Baron, J. A., et al., «Milk intake and risk of hip fracture in men and women: a meta-analysis of prospective cohort studies», en J Bone Miner Res., 26(4), 2011, pp. 833–839.

[21]. Feskanich, D., Bischoff-Ferrari, H. A., Frazier, A. L., Willett, W. C., «Milk consumption during teenage years and risk of hip fractures in older adults», en JAMA Pediatr., 168(1), 2014, pp. 54–60.

[22]. Michaëlsson, K., Wolk, A., Langenskiöld, S., et al., «Milk intake and risk of mortality and fractures in women and men: cohort studies», en BMJ, 349, 2014, p. g6015.

[23]. Batey, L. A., Welt, C.K., Rohr, F., et al., «Skeletal health in adult patients with classic galactosemia», en Osteoporos Int., 24(2), 2013, pp. 501–509.

[24]. Michaëlsson, K., Wolk, A., Langenskiöld, S., et al., «Milk intake and risk of mortality and fractures in women and men: cohort studies», en BMJ, 349, 2014, p. g6015.

[25]. Cui, X., Wang, L., Zuo, P., et al., «D-galactose-caused life shortening in Drosophila melanogaster and Musca domestica is associated with oxidative stress», en Biogerontology, 5(5), 2004, pp. 317–325.

[26]. Cui, X., Zuo, P., Zhang, Q., et al., «Chronic systemic D-galactose exposure induces memory loss, neurodegeneration, and oxidative damage in mice: protective effects of R-alpha-lipoic acid», en J Neurosci Res., 84(3), 2006, pp. 647–654.

[27]. Michaëlsson, K., Wolk, A., Langenskiöld, S., et al., «Milk intake and risk of mortality and fractures in women and men: cohort studies», en BMJ, 349, 2014, p. g6015.

[28]. Michaëlsson, K., Wolk, A., Langenskiöld, S., et al., «Milk intake and risk of mortality and fractures in women and men: cohort studies», en BMJ, 349, 2014, p. g6015.

[29]. Michaëlsson, K., Wolk, A., Langenskiöld, S., et al., «Milk intake and risk of mortality and fractures in women and men: cohort studies», en BMJ, 349, 2014, p. g6015.

[30]. Michaëlsson, K., Wolk, A., Langenskiöld, S., et al., «Milk intake and risk of mortality and fractures in women and men: cohort studies», en BMJ, 349, 2014, p. g6015.

[31]. Schooling, C. M., «Milk and mortality», en BMJ, 349, 2014, p. g6205.

[32]. Richman, E. L., Stampfer, M. J., Paciorek, A., Broering, J. M., Carroll, P. R., Chan, J. M., «Intakes of meat, fish, poultry, and eggs and risk of prostate cancer progression», en Am J Clin Nutr., 91(3), 2010, pp. 712–721.

[33]. Richman, E. L., Stampfer, M. J., Paciorek, A., Broering, J. M., Carroll, P. R., Chan, J. M., «Intakes of meat, fish, poultry, and eggs and risk of prostate cancer progression», en Am J Clin Nutr., 91(3), 2010, pp. 712–721.

[34]. Richman, E. L., Stampfer, M. J., Paciorek, A., Broering, J. M., Carroll, P. R., Chan, J. M., «Intakes of meat, fish, poultry, and eggs and risk of prostate cancer progression», en Am J Clin Nutr., 91(3), 2010, pp. 712–721.

[35]. Richman, E. L., Stampfer, M. J., Paciorek, A., Broering, J. M., Carroll, P. R., Chan, J. M., «Intakes of meat, fish, poultry, and eggs and risk of prostate cancer progression», en Am J Clin Nutr., 91(3), 2010, pp. 712–721.

[36]. Johansson, M., Van Guelpen, B., Vollset, S. E., et al., «One-carbon metabolism and prostate cancer risk: prospective investigation of seven circulating B vitamins and metabolites», en Cancer Epidemiol Biomarkers Prev., 18(5), 2009, pp. 1538–1543.

[37]. Richman, E. L., Stampfer, M. J., Paciorek, A., Broering, J. M., Carroll, P. R., Chan, J. M., «Intakes of meat, fish, poultry, and eggs and risk of prostate cancer progression», en Am J Clin Nutr., 91(3), 2010, pp. 712–721.

[38]. Richman, E. L., Kenfield, S. A., Stampfer, M. J., et al., «Choline intake and risk of lethal prostate cancer: incidence and survival», en Am J Clin Nutr., 96(4), 2012, pp. 855–863.

[39]. Richman, E. L., Kenfield, S. A., Stampfer, M. J., Giovannucci, E. L., Chan, J. M., «Egg, red meat, and poultry intake and risk of lethal prostate cancer in the prostate-specific antigen-era: incidence and survival», en Cancer Prev Res. (Filadelfia), 4(12), 2011, pp. 2110–2121.

[40]. Tang, W. H., Wang, Z., Levison, B. S., et al., «Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk», en N Engl J Med., 368(17), 2013, pp. 1575–1584.

[41]. Koeth, R. A., Wang, Z., Levison, B. S., et al., «Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis», en Nat Med., 19, 2013, pp. 576–585.

[42]. Tang, W. H., Wang, Z., Levison, B. S., et al., «Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk», en N Engl J Med., 368(17), 2013, pp. 1575–1584.

[43]. «Choline: there’s something fishy about this vitamin», en Harv Health Lett., 30(1), 2004, p. 3.

[44]. Mitch Kanter, Ph.D., comunicado vía e-mail, 6 de enero de 2010.

[45]. Hubbard, J. D., Inkeles, S., Barnard, R. J., «Nathan Pritikin’s heart», en N Engl J Med., 313(1), 1985, p. 52.

[46]. Ornish, D., Weidner, G., Fair, W. R., et al., «Intensive lifestyle changes may affect the progression of prostate cancer», en J Urol., 174(3), 2005, pp. 1065–1069.

[47]. Ornish, D., Weidner, G., Fair, W. R., et al., «Intensive lifestyle changes may affect the progression of prostate cancer», en J Urol., 174(3), 2005, pp. 1065–1069.

[48]. Barnard, R. J., Gonzalez, J. H., Liva, M. E., Ngo, T. H., «Effects of a low-fat, high-fiber diet and exercise program on breast cancer risk factors in vivo and tumor cell growth and apoptosis in vitro», en Nutr Cancer, 55(1), 2006, pp. 28–34.

[49]. Barnard, R. J., Ngo, T. H., Leung, P. S., Aronson, W. J., Golding, L. A., «A low-fat diet and/or strenuous exercise alters the IGF axis in vivo and reduces prostate tumor cell growth in vitro», en Prostate, 56(3), 2003, pp. 201–206.

[50]. Barnard, R. J., Ngo, T. H., Leung, P. S., Aronson, W. J., Golding, L. A., «A low-fat diet and/or strenuous exercise alters the IGF axis in vivo and reduces prostate tumor cell growth in vitro», en Prostate, 56(3), 2003, pp. 201–206.

[51]. Barnard, R. J., Ngo, T. H., Leung, P. S., Aronson, W. J., Golding, L. A., «A low-fat diet and/or strenuous exercise alters the IGF axis in vivo and reduces prostate tumor cell growth in vitro», en Prostate, 56(3), 2003, pp. 201–206.

[52]. Ornish, D., Weidner, G., Fair, W. R., et al., «Intensive lifestyle changes may affect the progression of prostate cancer», en J Urol., 174(3), 2005, pp. 1065–1069.

[53]. Ornish, D., Weidner, G., Fair, W. R., et al., «Intensive lifestyle changes may affect the progression of prostate cancer», en J Urol., 174(3), 2005, pp. 1065–1069.

[54]. Ornish, D., Magbanua, M. J., Weidner, G., et al., «Changes in prostate gene expression in men undergoing an intensive nutrition and lifestyle intervention», en Proc Natl Acad Sci USA, 105(24), 2008, pp. 8369–8374.

[55]. Frattaroli, J., Weidner, G., Dnistrian, A. M., et al., «Clinical events in prostate cancer lifestyle trial: results from two years of follow-up», en Urology, 72(6), 2008, pp. 1319–1323.

[56]. Frey, A. U., Sønksen, J., Fode, M., «Neglected side effects after radical prostatectomy: a systematic review», en J Sex Med., 11(2), 2014, pp. 374–385.

[57]. Carmody, J. F., Olendzki, B. C., Merriam, P. A., Liu, Q., Qiao, Y., Ma, Y., «A novel measure of dietary change in a prostate cancer dietary program incorporating mindfulness training», en J Acad Nutr Diet, 112(11), 2012, pp. 1822–1827.

[58]. Blanchard, C. M., Courneya, K. S., Stein, K., «Cancer survivors’ adherence to lifestyle behavior recommendations and associations with health-related quality of life: results from the American Cancer Society’s SCS-II», en J Clin Oncol., 26(13), 2008, pp. 2198–2204.

[59]. Carmody, J. F., Olendzki, B. C., Merriam, P. A., Liu, Q., Qiao, Y., Ma, Y., «A novel measure of dietary change in a prostate cancer dietary program incorporating mindfulness training», en J Acad Nutr Diet, 112(11), 2012, pp. 1822–1827.

[60]. Carmody, J. F., Olendzki, B. C., Merriam, P. A., Liu, Q., Qiao, Y., Ma, Y., «A novel measure of dietary change in a prostate cancer dietary program incorporating mindfulness training», en J Acad Nutr Diet, 112(11), 2012, pp. 1822–1827.

[61]. Carmody, J. F., Olendzki, B. C., Merriam, P. A., Liu, Q., Qiao, Y., Ma, Y., «A novel measure of dietary change in a prostate cancer dietary program incorporating mindfulness training», en J Acad Nutr Diet, 112(11), 2012, pp. 1822–1827.

[62]. Richman, E. L., Stampfer, M. J., Paciorek, A., Broering, J. M., Carroll, P. R., Chan, J. M., «Intakes of meat, fish, poultry, and eggs and risk of prostate cancer progressio», en Am J Clin Nutr., 91(3), 2010, pp. 712–721.

[63]. Richman, E. L., Carroll, P. R., Chan, J. M., «Vegetable and fruit intake after diagnosis and risk of prostate cancer progression», en Int J Cancer, 131(1), 2012, pp. 201–210.

[64]. Allen, N. E., Appleby, P. N., Key, T. J., et al., «Macronutrient intake and risk of urothelial cell carcinoma in the European prospective investigation into cancer and nutrition», en Int J Cancer, 132(3), 2013, pp. 635–644.

[65]. Morton, M. S., Chan, P. S., Cheng, C., et al., «Lignans and isoflavonoids in plasma and prostatic fluid in men: samples from Portugal, Hong Kong, and the United Kingdom», en Prostate, 32(2), 1997, pp. 122–128.

[66]. Van Die, M. D., Bone, K. M., Williams, S. G., Pirotta, M. V., «Soy and soy isoflavones in prostate cancer: a systematic review and meta-analysis of randomized controlled trials», en BJU Int., 113(5b), 2014, pp. E119–E130.

[67]. Morton, M. S., Chan, P. S., Cheng, C., et al., «Lignans and isoflavonoids in plasma and prostatic fluid in men: samples from Portugal, Hong Kong, and the United Kingdom», en Prostate, 32(2), 1997, pp. 122–128.

[68]. Lin, X., Switzer, B. R., Demark-Wahnefried, W., «Effect of mammalian lignans on the growth of prostate cancer cell lines», en Anticancer Res., 21(6A), 2001, pp. 3995–3999.

[69]. Demark-Wahnefried, W., Price, D. T., Polascik, T. J., et al., «Pilot study of dietary fat restriction and flaxseed supplementation in men with prostate cancer before surgery: exploring the effects on hormonal levels, prostate-specific antigen, and histopathologic features», en Urology, 58(1), 2001, pp. 47–52.

[70]. Leite, K. R., Camara-Lopes, L. H., Cury, J., Dall’oglio, M. F., Sañudo, A., Srougi, M., «Prostate cancer detection at rebiopsy after an initial benign diagnosis: results using sextant extended prostate biopsy», en Clinics (São Paulo), 63(3), 2008, pp. 339–342.

[71]. Demark-Wahnefried, W., Robertson, C. N., Walther, P. J., Polascik, T. J., Paulson, D. F., Vollmer, R. T., «Pilot study to explore effects of low-fat, flaxseed-supplemented diet on proliferation of benign prostatic epithelium and prostate-specific antigen», en Urology, 63(5), 2004, pp. 900–904.

[72]. Demark-Wahnefried, W., Polascik, T. J., George, S. L., et al., «Flaxseed supplementation (not dietary fat restriction) reduces prostate cancer proliferation rates in men presurgery», en Cancer Epidemiol Biomarkers Prev., 17(12), 2008, pp. 3577–3587.

[73]. Wei, J. T., Calhoun, E., Jacobsen, S. J., «Urologic Diseases in America Project: benign prostatic hyperplasia», en J Urol., 179(5 Suppl), 2008, pp. S75–S80.

[74]. Burnett, A. L., Wein, A. J., «Benign prostatic hyperplasia in primary care: what you need to know», en J Urol., 175(3 Pt 2), 2006, pp. S19–S24.

[75]. Taub, D. A., Wei, J. T., «The economics of benign prostatic hyperplasia and lower urinary tract symptoms in the United States», en Curr Urol Rep., 7(4), 2006, pp. 272–281.

[76]. Metcalfe, C., Poon, K. S., «Long-term results of surgical techniques and procedures in men with benign prostatic hyperplasia», en Curr Urol Rep., 12(4), 2011, pp. 265–273.

[77]. Burnett, A. L., Wein, A. J., «Benign prostatic hyperplasia in primary care: what you need to know», en J Urol., 175(3 Pt 2), 2006, pp. S19–S24.

[78]. Burnett, A. L., Wein, A. J., «Benign prostatic hyperplasia in primary care: what you need to know», en J Urol., 175(3 Pt 2), 2006, pp. S19–S24.

[79]. Gu, F., «Epidemiological survey of benign prostatic hyperplasia and prostatic cancer in China», en Chin Med J., 113(4), 2000, pp. 299–302.

[80]. Barnard, R. J., Kobayashi, N., Aronson, W. J., «Effect of diet and exercise intervention on the growth of prostate epithelial cells», en Prostate Cancer Prostatic Dis., 11(4), 2008, pp. 362–366.

[81]. Zhang, W., Wang, X., Liu, Y., et al., «Effects of dietary flaxseed lignan extract on symptoms of benign prostatic hyperplasia», en J Med Food, 11(2), 2008, pp. 207–214.

[82]. Galeone, C., Pelucchi, C., Talamini, R., et al., «Onion and garlic intake and the odds of benign prostatic hyperplasia», en Urology, 70(4), 2007, pp. 672–676.

[83]. Bravi, F., Bosetti, C., Dal Maso, L., et al., «Food groups and risk of benign prostatic hyperplasia», en Urology, 67(1), 2006, pp. 73–79.

[84]. Zhou, Z., Wang, Z., Chen, C., et al., «Transurethral prostate vaporization using an oval electrode in 82 cases of benign prostatic hyperplasia», en Chin Med J., 111(1), 1998, pp. 52–55.

[85]. Piantanelli, L., «Cancer and aging: from the kinetics of biological parameters to the kinetics of cancer incidence and mortality», en Ann N Y Acad Sci., 521, 1988, pp. 99–109.

[86]. Salvioli, S., Capri, M., Bucci, L., et al., «Why do centenarians escape or postpone cancer? The role of IGF-1, inflammation and p53», en Cancer Immunol Immunother, 58(12), 2009, pp. 1909–1917.

[87]. Reed, J. C., «Dysregulation of apoptosis in cancer», en J Clin Oncol., 17(9), 1999, pp. 2941–2953.

[88]. Rowlands, M. A., Gunnell, D., Harris, R., Vatten, L. J., Holly, J. M., Martin, R. M., «Circulating insulin-like growth factor peptides and prostate cancer risk: a systematic review and meta-analysis», en Int J Cancer, 124(10), 2009, pp. 2416–2429.

[89]. Guevara-Aguirre, J., Balasubramanian, P., Guevara-Aguirre, M., et al., «Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans», en Sci Transl Med., 3(70), 2011, p. 70ra13.

[90]. Allen, N. E., Appleby, P. N., Davey, G. K., Kaaks, R., Rinaldi, S., Key, T. J., «The associations of diet with serum insulin-like growth factor I and its main binding proteins in 292 women meat-eaters, vegetarians, and vegans», en Cancer Epidemiol Biomarkers Prev., 11(11), 2002, pp. 1441–1448.

[91]. Soliman, S., Aronson, W. J., Barnard, R. J., «Analyzing serum-stimulated prostate cancer cell lines after low-fat, high-fiber diet and exercise intervention», en Evid Based Complement Alternat Med., 2011, 2011, p. 529053.

[92]. Ngo, T. H., Barnard, R. J., Tymchuk, C. N., Cohen, P., Aronson, W. J., «Effect of diet and exercise on serum insulin, IGF-I, and IGFBP-1 levels and growth of LNCaP cells in vitro (Estados Unidos)», en Cancer Causes Control, 13(10), 2002, pp. 929–935.

[93]. Allen, N. E., Appleby, P. N., Davey, G. K., Key, T. J., «Hormones and diet: low insulin-like growth factor-I but normal bioavailable androgens in vegan men», en Br J Cancer, 83(1), 2000, pp. 95–97.

[94]. Allen, N. E., Appleby, P. N., Davey, G. K., Kaaks, R., Rinaldi, S., Key, T. J., «The associations of diet with serum insulin-like growth factor I and its main binding proteins in 292 women meat- eaters, vegetarians, and vegans», en Cancer Epidemiol Biomarkers Prev., 11(11), 2002, pp. 1441–1448.

 

 

14. No morir de enfermedad de Parkinson

 

[1]. Jafari, S., Etminan, M., Aminzadeh, F., Samii A., «Head injury and risk of Parkinson disease: a systematic review and meta-analysis», en Mov Disord., 28(9), 2013, pp. 1222–1229.

[2]. National Cancer Institute, «President’s Cancer Panel. Reducing environmental cancer risk: what we can do now», en <http://deainfo.nci.nih.gov/advisory/pcp/annualReports/pcp08-09rpt/PCP_Report_08-09_508.pdf>, abril de 2010. Último acceso 12 de marzo de 2015.

[3]. Zeliger, H. I., «Exposure to lipophilic chemicals as a cause of neurological impairments, neurodevelopmental disorders and neurodegenerative diseases», en Interdiscip Toxicol., 6(3), 2013, pp. 103–110.

[4]. Woodruff, T. J., Zota, A. R., Schwartz, J. M., «Environmental chemicals in pregnant women in the United States: NHANES 2003–2004», en Environ Health Perspect., 119(6), 2011, pp. 878–885.

[5]. Woodruff, T. J., Zota, A. R., Schwartz, J. M., «Environmental chemicals in pregnant women in the United States: NHANES 2003–2004», en Environ Health Perspect., 119(6), 2011, pp. 878–885.

[6]. Mariscal-Arcas, M., Lopez-Martinez, C., Granada, A., Olea, N., Lorenzo-Tovar, M. L., Olea-Serrano, F., «Organochlorine pesticides in umbilical cord blood serum of women from Southern Spain and adherence to the Mediterranean diet», en Food Chem Toxicol., 48(5), 2010, pp. 1311–1315.

[7]. Bjermo, H., Darnerud, P. O., Lignell, S., et al., «Fish intake and breastfeeding time are associated with serum concentrations of organochlorines in a Swedish population», en Environ Int., 51, 2013, pp. 88–96.

[8]. Glynn, A., Larsdotter, M., Aune, M., Darnerud, P. O., Bjerselius, R., Bergman, A., «Changes in serum concentrations of polychlorinated biphenyls (PCBs), hydroxylated PCB metabolites and pentachlorophenol during pregnancy», en Chemosphere, 83(2), 2011, pp. 144–151.

[9]. Soechitram, S. D., Athanasiadou, M., Hovander, L., Bergman, A., Sauer, P. J., «Fetal exposure to PCBs and their hydroxylated metabolites in a Dutch cohort», en Environ Health Perspect., 112(11), 2004, pp. 1208–1212.

[10]. Ulaszewska, M. M., Zuccato, E., Davoli, E., «PCDD/Fs and dioxin-like PCBs in human milk and estimation of infants’ daily intake: a review», en Chemosphere, 83(6), 2011, pp. 774–782.

[11]. Gallo, M. V., Schell, L. M., Decaprio, A. P., Jacobs, A., «Levels of per sis tent organic pollutant and their predictors among young adults», en Chemosphere, 83(10), 2011, pp. 1374–1382.

[12]. Ulaszewska, M. M., Zuccato, E., Davoli, E., «PCDD/Fs and dioxin-like PCBs in human milk and estimation of infants’ daily intake: a review», en Chemosphere, 83(6), 2011, pp. 774–782.

[13]. Aliyu, M. H., Alio, A. P., Salihu, H. M., «To breastfeed or not to breastfeed: a review of the impact of lactational exposure to polychlorinated biphenyls (PCBs) on infants», en J Environ Health, 73(3), 2010, pp. 8–14.

[14]. Vogt, R., Bennett, D., Cassady, D., Frost, J., Ritz, B., Hertz-Picciotto, I., «Cancer and non-cancer health effects from food contaminant exposures for children and adults in California: a risk assessment», en Environ Health, 11, 2012, p. 83.

[15]. Vogt, R., Bennett, D., Cassady, D., Frost, J., Ritz, B., Hertz-Picciotto, I., «Cancer and non-cancer health effects from food contaminant exposures for children and adults in California: a risk assessment», en Environ Health, Table S3, <http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551655/bin/1476-069X-11-83-S3.doc>, 11, 2012. Último acceso 28 de marzo de 2015.

[16]. Vogt, R., Bennett, D., Cassady, D., Frost, J., Ritz, B., Hertz-Picciotto, I., «Cancer and non-cancer health effects from food contaminant exposures for children and adults in California: a risk assessment», en Environ Health, 11, 2012, p. 83.

[17]. Dórea, J. G., Bezerra, V. L., Fajon, V., Horvat, M., «Speciation of methyl- and ethyl-mercury in hair of breastfed infants acutely exposed to thimerosal-containing vaccines», en Clin Chim Acta., 412(17–18), 2011, pp. 1563–1566.

[18]. Zeilmaker, M. J., Hoekstra, J., Van Eijkeren, J. C., et al., «Fish consumption during child bearing age: a quantitative risk-benefit analysis on neurodevelopment», en Food Chem Toxicol., 54, 2013, pp. 30–34.

[19]. Fromberg, A., Granby, K., Højgård, A., Fagt, S., Larsen, J. C., «Estimation of dietary intake of PCB and organochlorine pesticides for children and adults», en Food Chem., 125, 2011, pp. 1179–1187.

[20]. European Food Safety Authority, «Results of the monitoring of non dioxin-like PCBs in food and feed», en EFSA Journal, 8(7), 2010, p. 1701.

[21]. Fromberg, A., Granby, K., Højgård, A., Fagt, S., Larsen, J. C., «Estimation of dietary intake of PCB and organochlorine pesticides for children and adults», en Food Chem., 125, 2011, pp. 1179–1187.

[22]. Zhang, T., Sun, H. W., Wu, Q., Zhang, X. Z., Yun, S. H., Kannan, K., «Perfl uorochemicals in meat, eggs and indoor dust in China: assessment of sources and pathways of human exposure to perfluorochemicals», en Environ Sci Technol., 44(9), 2010, pp. 3572–3579.

[23]. Schecter, A., Cramer, P., Boggess, K., et al., «Intake of dioxins and related compounds from food in the U.S. population», en J Toxicol Environ Health Part A, 63(1), 2001, pp. 1–18.

[24]. Aune, D., De Stefani, E., Ronco, A. L., et al., «Egg consumption and the risk of cancer: a multisite case-control study in Uruguay», en Asian Pac J Cancer Prev., 10(5), 2009, pp. 869–876.

[25]. Yaginuma-Sakurai, K., Murata, K., Iwai-Shimada, M., et al., «Hair-to-blood ratio and biological halflife of mercury: experimental study of methylmercury exposure through fish consumption in humans», en J Toxicol Sci., 37(1), 2012, pp. 123–130.

[26]. Wimmerová, S., Lancz, K., Tihányi, J., et al., «Half-lives of serum PCB congener concentrations in environmentally exposed early adolescents», en Chemosphere, 82(5), 2011, 687–691.

[27]. Hageman, K. J., Hafner, W. D., Campbell, D. H., Jaffe, D. A., Landers, D. H., Simonich, S. L., «Variability in pesticide deposition and source contributions to snowpack in Western U.S. national parks», en Environ Sci Technol., 44(12), 2010, pp. 4452–4458.

[28]. Schecter, A., Startin, J., Wright, C., et al., «Congener-specific levels of dioxins and dibenzofurans in U.S. food and estimated daily dioxin toxic equivalent intake», en Environ Health Perspect., 102(11), 1994, pp. 962–966.

[29]. Fiedler, H., Cooper, K. R., Bergek, S., Hjelt, M., Rappe, C., «Polychlorinated dibenzo-p-dioxins and polychlorinated dibenzofurans (PCDD/PCDF) in food samples collected in southern Mississippi, USA», en Chemosphere, 34(5–7), 1997, pp. 1411–1419.

[30]. Rappe, C., Bergek, S., Fiedler, H., Cooper, K. R., «PCDD and PCDF contamination in catfish feed from Arkansas, USA», en Chemosphere, 36(13), 1998, pp. 2705–2720.

[31]. Ferrario, J. B., Byrne, C. J., Cleverly, D. H., «2,3,7,8-Dibenzo-p-dioxins in mined clay products from the United States: evidence for possible natural origin», en Environ Sci Technol., 34(21), 2000, pp. 4524–4532.

[32]. US Department of Commerce, «Broiler, turkey, and egg production: 1980 to 1999, No. 1143, p. 684», en Statistical Abstract of the United States, 2000, Government Printing Office, Washington, D. C., 2000.

[33]. Hayward, D. G., Nortrup, D., Gardner, A., Clower, M., «Elevated TCDD in chicken eggs and farmraised catfish fed a diet with ball clay from a Southern United States mine», en Environ Res., 81(3), 1999, pp. 248–256.

[34]. Hayward, D. G., Nortrup, D., Gardner, A., Clower, M., «Elevated TCDD in chicken eggs and farmraised catfish fed a diet with ball clay from a Southern United States mine», en Environ Res., 81(3), 1999, pp. 248–256.

[35]. US Food and Drug Administration, «Letter from Linda Tollefson to Producers or Users of Clay Products in Animal Feeds», en <https://web.archive.org/web/20081107120600/http://www.fda.gov/cvm/Documents/ballclay.pdf>, 7 de octubre de 1997. Último acceso 12 de marzo de 2015.

[36]. Hanson, T., Sites, D., «2012 US catfish database. Fisheries and Allied Aquacultures Department Series No. 6», en <http://aurora.auburn.edu/repo/bitstream/handle/11200/44174/2012%20Catfish%20 Database.pdf?sequence=1>, marzo de 2013. Último acceso 26 de marzo de 2015.

[37]. Huwe, J. K., Archer, J. C., «Dioxin congener patterns in commercial catfi sh from the United States and the indication of mineral clays as the potential source», en Food Addit Contam Part A Chem Anal Control Expo Risk Assess., 30(2), 2013, pp. 331–338.

[38]. Rappe, C., Bergek, S., Fiedler, H., Cooper, K. R., «PCDD and PCDF contamination in catfish feed from Arkansas, USA», en Chemosphere, 36(13), 1998, pp. 2705–2720.

[39]. Yaktine, A. L., Harrison, G. G., Lawrence, R. S., «Reducing exposure to dioxins and related compounds through foods in the next generation», en Nutr Rev., 64(9), 2006, pp. 403–409.

[40]. Schecter, A., Startin, J., Wright, C., et al., «Congener-specific levels of dioxins and dibenzofurans in U.S. food and estimated daily dioxin toxic equivalent intake», en Environ Health Perspect., 102(11), 1994, pp. 962–966.

[41]. US Department of Health and Human Services, «The Health Consequences of Smoking: 50 Years of Progress. A Report of the Surgeon General», US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, en Atlanta, Georgia, 2014.

[42]. Lee, P. N., «1979 Surgeon General’s Report», en <http://legacy.library.ucsf.edu/tid/zkl36b00/pdf?search=%221979%20surgeon%20general%20s%20re port%20lee%22>, 2 de septiembre de 1979. Último acceso 12 de marzo de 2015.

[43]. Lee, P. N., «1979 Surgeon General’s Report», en <http://legacy.library.ucsf.edu/tid/zkl36b00/pdf?search=%221979%20surgeon%20general%20s%20re port%20lee%22>, 2 de septiembre de 1979. Último acceso 12 de marzo de 2015.

[44]. «Hearings before the Subcommittee on Public Buildings and Grounds of the Committee on Public Works and Transportation to Prohibit Smoking in Federal Buildings», en <http://legacy.library.ucsf.edu/tid/fzt08h00/pdf?search=%22to%20prohibit%20smoking%20in%20federal%20buildings%20hearings%20jd%20047710%22>, 11 de marzo y 22 de abril de 1993. Último acceso 12 de marzo de 2015.

[45]. Noyce, A. J., Bestwick, J. P., Silveira-Moriyama, L., et al., «Meta-analysis of early nonmotor features and risk factors for Parkinson disease», en Ann Neurol., 72(6), 2012, pp. 893–901.

[46]. Morens, D. M., Grandinetti, A., Davis, J. W., Ross, G. W., White, L. R., Reed, D., «Evidence against the operation of selective mortality in explaining the association between cigarette smoking and reduced occurrence of idiopathic Parkinson disease», en Am J Epidemiol., 144(4), 1996, pp. 400–404.

[47]. Noyce, A. J., Bestwick, J. P., Silveira-Moriyama, L., et al., «Meta-analysis of early nonmotor features and risk factors for Parkinson disease», en Ann Neurol., 72(6), 2012, pp. 893–901.

[48]. Allam, M. F., Campbell, M. J., Del Castillo, A. S., Fernández-Crehuet Navajas, R., «Parkinson’s disease protects against smoking?», en Behav Neurol., 15(3–4), 2004, pp. 65–71.

[49]. Tanner, C. M., Goldman, S. M., Aston, D. A., et al., «Smoking and Parkinson’s disease in twins», en Neurology, 58(4), 2002, pp. 581–588.

[50]. O’Reilly, E. J., Chen, H., Gardener, H., Gao, X., Schwarzschild, M. A., Ascherio, A., «Smoking and Parkinson’s disease: using parental smoking as a proxy to explore causality», en Am J Epidemiol., 169(6), 2009, pp. 678–682.

[51]. US Department of Health and Human Services, «The Health Consequences of Smoking: 50 Years of Progress. A Report of the Surgeon General», US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, en Atlanta, Georgia, 2014.

[52]. Wolf, P. A., D’Agostino, R. B., Kannel, W. B., Bonita, R., Belanger, A. J., «Cigarette smoking as a risk factor for stroke, The Framingham Study«, en JAMA, 259(7), 1988, pp. 1025–1029.

[53]. Quik, M., Perez, X. A., Bordia, T., «Nicotine as a potential neuroprotective agent for Parkinson’s disease», en Mov Disord., 27(8), 2012, pp. 947–957.

[54]. Siegmund, B., Leitner, E., Pfannhauser, W., «Determination of the nicotine content of various edible nightshades (Solanaceae) and their products and estimation of the associated dietary nicotine intake», en J Agric Food Chem., 47(8), 1999, pp. 3113–3120.

[55]. Brody, A. L., Mandelkern, M. A., London, E. D., et al., «Cigarette smoking saturates brain alpha 4 beta 2 nicotinic acetylcholine receptors», en Arch Gen Psychiatry., 63(8), 2006, pp. 907–915.

[56]. Searles Nielsen, S., Gallagher, L. G., Lundin, J. I., et al., «Environmental tobacco smoke and Parkinson’s disease», en Mov Disord., 27(2), 2012, pp. 293–296.

[57]. Siegmund, B., Leitner, E., Pfannhauser, W., «Determination of the nicotine content of various edible nightshades (Solanaceae) and their products and estimation of the associated dietary nicotine intake», en J Agric Food Chem., 47(8), 1999, pp. 3113–3120.

[58]. Nielsen, S. S., Franklin, G. M., Longstreth, W. T., Swanson, P. D., Checkoway, H., «Nicotine from edible Solanaceae and risk of Parkinson disease», en Ann Neurol., 74(3), 2013, pp. 472–477.

[59]. Nielsen, S. S., Franklin, G. M., Longstreth, W. T., Swanson, P. D., Checkoway, H., «Nicotine from edible Solanaceae and risk of Parkinson disease», en Ann Neurol., 74(3), 2013, pp. 472–477.

[60]. Richardson, J. R., Shalat, S. L., Buckley, B., et al., «Elevated serum pesticide levels and risk of Parkinson disease», en Arch Neurol., 66(7), 2009, pp. 870–875.

[61]. Corrigan, F. M., Wienburg, C. L., Shore, R. F., Daniel, S. E., Mann, D., «Organochlorine insecticides in substantia nigra in Parkinson’s disease», en J Toxicol Environ Health Part A, 59(4), 2000, pp. 229–234.

[62]. Hatcher-Martin, J. M., Gearing, M., Steenland, K., Levey, A. I., Miller, G. W., Pennell, K. D., «Association between polychlorinated biphenyls and Parkinson’s disease neuropathology», en Neurotoxicology, 33(5), 2012, pp. 1298–1304.

[63]. Kanthasamy, A. G., Kitazawa, M., Kanthasamy, A., Anantharam, V., «Dieldrin-induced neurotoxicity: relevance to Parkinson’s disease pathogenesis», en Neurotoxicology, 26(4), 2005, pp. 701–719.

[64]. Arguin, H., Sánchez, M., Bray, G. A., et al., «Impact of adopting a vegan diet or an olestra supplementation on plasma organochlorine concentrations: results from two pilot studies», en Br J Nutr., 103(10), 2010, pp. 1433–1441.

[65]. Jiang, W., Ju, C., Jiang, H., Zhang, D., «Dairy foods intake and risk of Parkinson’s disease: a doseresponse meta-analysis of prospective cohort studies», en Eur J Epidemiol., 29(9), 2014, pp. 613–619.

[66]. Park, M., Ross, G. W., Petrovitch, H., et al., «Consumption of milk and calcium in midlife and the future risk of Parkinson disease», en Neurology, 64(6), 2005, pp. 1047–1051.

[67]. Kotake, Y., Yoshida, M., Ogawa, M., Tasaki, Y., Hirobe, M., Ohta, S., «Chronic administration of 1-benzyl-1,2,3,4-tetrahydroisoquinoline, an endogenous amine in the brain, induces parkinsonism in a primate», en Neurosci Lett., 217(1), 1996, pp. 69–71.

[68]. Niwa, T., Yoshizumi, H., Takeda, N., Tatematsu, A., Matsuura, S., Nagatsu, T., «Detection of tetrahy-droisoquinoline, a parkinsonism-related compound, in parkinsonian brains and foods by gas chromatography-mass spectrometry», en Advances in Behavioral Biology., 38A, 1990, pp. 313–316.

[69]. Niwa, T., Yoshizumi, H., Tatematsu, A., Matsuura, S., Nagatsu, T., «Presence of tetrahydroisoquinoline, a parkinsonism-related compound, in foods», en J Chromatogr., 493(2), 1989, pp. 347–352.

[70]. Niwa, T., Takeda, N., Kaneda, N., Hashizume, Y., Nagatsu, T., «Presence of tetrahydroisoquinoline and 2-methyl-tetrahydroquinoline in parkinsonian and normal human brains», en Biochem Biophys Res Commun., 144(2), 1987, pp. 1084–1089.

[71]. Ułamek-Kozioł, M., Bogucka-Kocka, A., Kocki, J., Pluta, R., «Good and bad sides of diet in Parkinson’s disease», en Nutrition, 29(2), 2013, pp. 474–475.

[72]. Ułamek-Kozioł, M., Bogucka-Kocka, A., Kocki, J., Pluta, R., «Good and bad sides of diet in Parkinson’s disease», en Nutrition, 29(2), 2013, pp. 474–475.

[73]. Kistner, A., Krack, P., «Parkinson’s disease: no milk today?», en Front Neurol., 5, 2014, p. 172.

[74]. Chen, H., Zhang, S. M., Hernn, M. A., Willett, W. C., Ascherio, A., «Diet and Parkinson’s disease: a potential role of dairy products in men», en Ann Neurol., 52(6), 2002, pp. 793–801.

[75]. Jiang, W., Ju, C., Jiang, H., Zhang, D., «Dairy foods intake and risk of Parkinson’s disease: a doseresponse meta-analysis of prospective cohort studies», en Eur J Epidemiol., 29(9), 2014, pp. 613–619.

[76]. Michaëlsson, K., Wolk, A., Langenskiöld, S., et al., «Milk intake and risk of mortality and fractures in women and men: cohort studies», en BMJ, 349, 2014, p. g6015.

[77]. Ridel, K. R., Leslie, N. D., Gilbert, D. L., «An updated review of the long-term neurological effects of galactosemia», en Pediatr Neurol., 33(3), 2005, pp. 153–161.

[78]. Marder, K., Gu, Y., Eberly, S., et al., «Relationship of Mediterranean diet and caloric intake to phenoconversion in Huntington disease», en JAMA Neurol., 70(11), 2013, pp. 1382–1388.

[79]. Ames, B. N., Cathcart, R., Schwiers, E., Hochstein, P., «Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis», en Proc Natl Acad Sci USA, 78(11), 1981, pp. 6858–6862.

[80]. Duan, W., Ladenheim, B., Cutler, R. G., Kruman, I. I., Cadet, J. L., Mattson, M. P., «Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson’s disease», en J Neurochem., 80(1), 2002, pp. 101–110.

[81]. Auinger, P., Kieburtz, K., McDermott, M. P., «The relationship between uric acid levels and Huntington’s disease progression», en Mov Disord., 25(2), 2010, pp. 224–228.

[82]. Schwarzschild, M. A., Schwid, S. R., Marek, K., et al., «Serum urate as a predictor of clinical and radiographic progression in Parkinson disease», en Arch Neurol., 65(6), 2008, pp. 716–723.

[83]. Shen, C., Guo, Y., Luo, W., Lin, C., Ding, M., «Serum urate and the risk of Parkinson’s disease: results from a meta-analysis», en Can J Neurol Sci., 40(1), 2013, pp. 73–79.

[84]. Fang, P., Li, X., Luo, J. J., Wang, H., Yang, X., «A double-edged sword: uric acid and neurological disorders», en Brain Disord Ther., 2(2), 2013, p. 109.

[85]. Kutzing, M. K., Firestein, B. L., «Altered uric acid levels and disease states», en J Pharmacol Exp Ther., 324(1), 2008, pp. 1–7.

[86]. Schmidt, J. A., Crowe, F. L., Appleby, P. N., Key, T. J., Travis, R. C., «Serum uric acid concentrations in meat eaters, fish eaters, vegetarians and vegans: a cross-sectional analysis in the EPIC-Oxford cohort», en PLoS ONE, 8(2), 2013, p. e56339.

[87]. Kuo, C. F., See, L. C., Yu, K. H., Chou, I. J., Chiou, M. J., Luo, S. F., «Significance of serum uric acid levels on the risk of all-cause and cardiovascular mortality», en Rheumatology (Oxford), 52(1), 2013, pp. 127–134.

[88]. Arguin, H., Sánchez, M., Bray, G. A., et al., «Impact of adopting a vegan diet or an olestra supplementation on plasma organochlorine concentrations: results from two pilot studies», en Br J Nutr., 103(10), 2010, pp. 1433–1441.

[89]. Siddiqui, M. K., Saxena, M. C., Krishna Murti, C. R., «Storage of DDT and BHC in adipose tissue of Indian males», en Int J Environ Anal Chem., 10(3–4), 1981, pp. 197–204.

[90]. Norén, K., «Levels of organochlorine contaminants in human milk in relation to the dietary habits of the mothers», en Acta Paediatr Scand., 72(6), 1983, pp. 811–816.

[91]. Schecter, A., Papke, O., «Comparison of blood dioxin, dibenzofuran and coplanar PCB levels in strict vegetarians (vegans) and the general United States population», en Org Comps., 38, 1998, pp. 179–182.

[92]. Schecter, A., Harris, T. R., Päpke, O., Tunga, K. C., Musumba, A., «Polybrominated diphenyl ether (PBDE) levels in the blood of pure vegetarians (vegans)», en Tox Env Chem., 88(1), 2006, pp. 107–112.

[93]. Eskenazi, B., Chevrier, J., Rauch, S. A., et al., «In utero and childhood polybrominated diphenyl ether (PBDE) exposures and neurodevelopment in the CHAMACOS study», en Environ Health Perspect., 121(2), 2013, pp. 257–262.

[94]. Schecter, A., Päpke, O., Harris, T. R., et al., «Polybrominated diphenyl ether (PBDE) levels in an expanded market basket survey of U.S. food and estimated PBDE dietary intake by age and sex», en Environ Health Perspect., 114(10), 2006, pp. 1515–1520.

[95]. Fraser, A. J., Webster, T. F., McClean, M. D., «Diet contributes significantly to the body burden of PBDEs in the general U.S. population», en Environ Health Perspect., 117(10), 2009, pp. 1520–1525.

[96]. Schecter, A., Harris, T. R., Päpke, O., Tunga, K. C., Musumba, A., «Polybrominated diphenyl ether (PBDE) levels in the blood of pure vegetarians (vegans)», en Tox Env Chem., 88(1), 2006, pp. 107–112.

[97]. Huwe, J. K., West, M., «Polybrominated diphenyl ethers in U.S. meat and poultry from two statistically designed surveys showing trends and levels from 2002 to 2008», en J Agric Food Chem., 59(10), 2011, pp. 5428–5434.

[98]. Dickman, M. D., Leung, C. K., Leong, M. K., «Hong Kong male subfertility links to mercury in human hair and fish», en Sci Total Environ., 214, 1998, pp. 165–174.

[99]. Srikumar, T. S., Johansson, G. K., Ockerman, P. A., Gustafsson, J. A., Akesson, B., «Trace element status in healthy subjects switching from a mixed to a lactovegetarian diet for 12 mo», en Am J Clin Nutr., 55(4), 1992, pp. 885–890.

[100]. Wimmerová, S., Lancz, K., Tihányi, J., et al., «Half-lives of serum PCB congener concentrations in environmentally exposed early adolescents», en Chemosphere, 82(5), 2011, pp. 687–691.

[101]. Parkinson, J., An Essay on the Shaking Palsy, Whittingham and Rowland for Sherwood, Neely and Jones, Londres, 1817, p. 7.

[102]. Abbott, R. D., Petrovitch, H., White, L. R., et al., «Frequency of bowel movements and the future risk of Parkinson’s disease», en Neurology., 57(3), 2001, pp. 456–462.

[103]. Ueki, A., Otsuka, M., «Life style risks of Parkinson’s disease: association between decreased water intake and constipation», en J Neurol., 251 Suppl 7, 2004, pp. vII18–vII23.

[104]. Gao, X., Chen, H., Schwarzschild, M. A., Ascherio, A., «A prospective study of bowel movement frequency and risk of Parkinson’s disease», en Am J Epidemiol., 174(5), 2011, pp. 546–551.

[105]. Kamel, F., «Epidemiology. Paths from pesticides to Parkinson’s», en Science, 341(6147), 2013, pp. 722–723.

[106]. Barnhill, L. M., Bronstein, J. M., «Pesticides and Parkinson’s disease: is it in your genes?», en Neurodegener Dis Manag., 4(3), 2014, pp. 197–200.

[107]. Wang, A., Cockburn, M., Ly, T. T., Bronstein, J. M., Ritz, B., «The association between ambient exposure to organophosphates and Parkinson’s disease risk», en Occup Environ Med., 71(4), 2014, pp. 275–281.

[108]. Narayan, S., Liew, Z., Paul, K., et al., «House hold organophosphorus pesticide use and Parkinson’s disease», en Int J Epidemiol., 42(5), 2013, pp. 1476–1485.

[109]. Liu, X., Ma, T., Qu, B., Ji, Y., Liu, Z., «Pesticide-induced gene mutations and Parkinson disease risk: a meta-analysis», en Genet Test Mol Biomarkers, 17(11), 2013, pp. 826–832.

[110]. Lee, S. J., Lim, H. S., Masliah, E., Lee, H. J., «Protein aggregate spreading in neurodegenerative diseases: problems and perspectives», en Neurosci Res., 70(4), 2011, pp. 339–348.

[111]. Chorfa, A., Lazizzera, C., Bétemps, D., et al., «A variety of pesticides trigger in vitro α-synuclein accumulation, a key event in Parkinson’s disease», en Arch Toxicol., 2014.

[112]. Dunnett, S. B., Björklund, S. B. A., «Prospects for new restorative and neuroprotective treatments in Parkinson’s disease», en Nature, 399(6738 Suppl), 1999, pp. A32–A39.

[113]. Campdelacreu, J., «Parkinson disease and Alzheimer disease: environmental risk factors», en Neurologia, 29(9), 2014, pp. 541–549.

[114]. Meng, X., Munishkina, L. A., Fink, A. L., Uversky, V. N., «Effects of various flavonoids on the α-synuclein fibrillation process», en Parkinson’s Dis., 2010, 2010, p. 650794.

[115]. Strathearn, K. E, Yousef, G. G., Grace, M. H., Roy, S. A., et al., «Neuroprotective effects of anthocyaninand proanthocyanidin-rich extracts in cellular models of Parkinson’s disease», en Brain Res., 1555, 2014, pp. 60–77.

[116]. Golbe, L. I., Farrell, T. M., Davis, P. H., «Case-control study of early life dietary factors in Parkinson’s disease», en Arch Neurol., 45(12), 1988, pp. 1350–1353.

[117]. Gao, X., Cassidy, A., Schwarzschild, M. A., Rimm, E. B., Ascherio, A., «Habitual intake of dietary flavonoids and risk of Parkinson disease», en Neurol., 78(15), 2012, pp. 1138–1145.

[118]. Kukull, W. A., «An apple a day to prevent Parkinson disease: reduction of risk by flavonoids», en Neurol., 78(15), 2012, pp. 1112–1113.

[119]. Gao, X., Cassidy, A., Schwarzschild, M. A., Rimm, E. B., Ascherio, A., «Habitual intake of dietary flavonoids and risk of Parkinson disease», en Neurol., 78(15), 2012, pp. 1138–1145.

[120]. Serafini, M., Testa, M. F., Villain, D., et al., «Antioxidant activity of blueberry fruit is impaired by association with milk», en Free Radic Biol Med., 46(6), 2009, pp. 769–774.

[121]. Jekanowski, M., «Survey says: a snapshot of rendering», en Render Magazine, abril de 2011, pp. 58–61.

[122]. Schepens, P. J., Covaci, A., Jorens, P. G., Hens, L., Scharpé, S., Van Larebeke, N., «Surprising findings following a Belgian food contamination with polychlorobiphenyls and dioxins», en Environ Health Perspect., 109(2), 2001, pp. 101–103.

[123]. Dórea, J. G., «Vegetarian diets and exposure to organochlorine pollutants, lead, and mercury», en Am J Clin Nutr., 80(1), 2004, pp. 237–238.

[124]. Dórea, J. G., «Fish meal in animal feed and human exposure to persistent bioaccumulative and toxic substances», en J Food Prot., 69(11), 2006, pp. 2777–2785.

[125]. Moser, G. A., McLachlan, M. S., «The influence of dietary concentration on the absorption and excretion of persistent lipophilic organic pollutants in the human intestinal tract», en Chemosphere, 45(2), 2001, pp. 201–211.

[126]. Dórea, J. G., «Vegetarian diets and exposure to organochlorine pollutants, lead, and mercury», en Am J Clin Nutr., 80(1), 2004, pp. 237–238.

[127]. Noyce, A. J., Bestwick, J. P., Silveira-Moriyama, L., et al., «Meta-analysis of early nonmotor features and risk factors for Parkinson disease», en Ann Neurol., 72(6), 2012, pp. 893–901.

[128]. Barranco Quintana, J. L., Allam, M. F., Del Castillo, A. S., Navajas, R. F., «Parkinson’s disease and tea: a quantitative review», en J Am Coll Nutr., 28(1), 2009, pp. 1–6.

[129]. Palacios, N., Gao, X., McCullough, M. L., et al., «Caffeine and risk of Parkinson’s disease in a large cohort of men and women», en Mov Disord., 27(10), 2012, pp. 1276–1282.

[130]. Nakaso, K., Ito, S., Nakashima, K., «Caffeine activates the PI3K/Akt pathway and prevents apoptotic cell death in a Parkinson’s disease model of SH- SY5Y cells», en Neurosci Lett., 432(2), 2008, pp. 146–150.

[131]. Postuma, R. B., Lang, A. E., Munhoz, R. P., et al., «Caffeine for treatment of Parkinson disease: a randomized controlled trial», en Neurology, 79(7), 2012, pp. 651–658.

[132]. Postuma, R. B., Lang, A. E., Munhoz, R. P., et al., «Caffeine for treatment of Parkinson disease: a randomized controlled trial», en Neurology, 79(7), 2012, pp. 651–658.

[133]. Grazina, R., Massano, J., «Physical exercise and Parkinson’s disease: influence on symptoms, disease course and prevention», en Rev Neurosci., 24(2), 2013, pp. 139–152.

[134]. Chen, J., Guan, Z., Wang, L., Song, G., Ma, B., Wang, Y., «Meta-analysis: overweight, obesity, and Parkinson’s disease», en Int J Endocrinol., 2014, 2014, p. 203930.

 

 

15. No morir de causas iatrogénicas

 

[1]. Pereira, T. V., Horwitz, R. I., Ioannidis, J. P. A., «Empirical evaluation of very large treatment effects of medical interventions», en JAMA, 308(16), 2012, pp. 1676–1684.

[2]. Lazarou, J., Pomeranz, B. H., Corey, P. N., «Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies», en JAMA, 279(15), 1198, pp. 1200–1205.

[3]. Starfield, B., «Is US health really the best in the world?», en JAMA, 284(4), 2000, pp. 483–485.

[4]. Klevens, R. M., Edwards, J. R., Richards, C. L., et al., «Estimating health care-associated infections and deaths in U.S. hospitals, 2002», en Public Health Rep., 122(2), 2007, pp. 160–166.

[5]. Gilbert, K., Stafford, C., Crosby, K., Fleming, E., Gaynes, R., «Does hand hygiene compliance among health care workers change when patients are in contact precaution rooms in ICUs?», en Am J Infect Control, 38(7), 2010, pp. 515–517.

[6]. Gilbert, K., Stafford, C., Crosby, K., Fleming, E., Gaynes, R., «Does hand hygiene compliance among health care workers change when patients are in contact precaution rooms in ICUs?», en Am J Infect Control, 38(7), 2010, pp. 515–517.

[7]. Leape, L. L., Berwick, D. M., «Five years after To Err Is Human: what have we learned?», en JAMA, 293(19), 2005, pp. 2384–2390.

[8]. Starfield, B., «Is US health really the best in the world?», en JAMA, 284(4), 2000, pp. 483–485.

[9]. Institute of Medicine, «To Err Is Human: building a safer health system», en <http://www.iom.edu/~/media/Files/Report%20Files/1999/To-Err-is-Human/To%20Err%20is%20Human%201999%20%20report%20brief.pdf>, noviembre de 1999. Último acceso 12 de marzo de 2015.

[10]. Weingart, S. N., Wilson, R. M., Gibberd, R. W., Harrison, B., «Epidemiology of medical error», en BMJ, 320(7237), 2000, pp. 774–777.

[11]. Millenson, M. L., «The silence», en Health Aff. (Millwood), 22(2), 2003, pp. 103–112.

[12]. Mills, D. H., «Medical insurance feasibility study. A technical summary», en West J Med., 128(4), 1978, pp. 360–365.

[13]. Leape, L. L., «Error in medicine», en JAMA. 272(23), 21 de diciembre de 1994, pp. 1851–1857.

[14]. Millenson, M. L., «The silence», en Health Aff. (Millwood), 22(2), 2003, pp. 103–112.

[15]. Institute of Medicine, «To Err Is Human: building a safer health system», en <http://www.iom.edu/~/media/Files/Report%20Files/1999/To-Erris-Human/To%20Err%20is%20Human%201999%20%20report%20brief.pdf>, noviembre de 1999. Último acceso 12 de marzo de 2015.

[16]. Millenson, M. L., «The silence», en Health Aff. (Millwood), 22(2), 2003, pp. 103–112.

[17]. Lockley, S. W., Barger, L. K., Ayas, N. T., Rothschild, J. M., Czeisler, C. A., Landrigan, C. P., «Effects of health care provider work hours and sleep deprivation on safety and performance», en Jt Comm J Qual Patient Saf., 33(11 Suppl), 2007, pp. 7–18.

[18]. Barger, L. K., Ayas, N. T., Cade, B. E., et al., «Impact of extended-duration shifts on medical errors, adverse events, and attentional failures», en PLoS Med., 3(12), 2006, p. e487.

[19]. Millenson, M. L., «The silence», en Health Aff. (Millwood), 22(2), 2003, pp. 103–112.

[20]. Egger, G. J., Binns, A. F., Rossner, S. R., «The emergence of “lifestyle medicine” as a structured approach for management of chronic disease», en Med J Aust., 190(3), 2009, pp. 143–145.

[21]. Malone, J., Guleria, R., Craven, C., et al., «Justification of diagnostic medical exposures: some practical issues. Report of an International Atomic Energy Agency Consultation», en Br J Radiol., 85(1013), 2012, pp. 523–538.

[22]. Pierce, D. A., Shimizu, Y., Preston, D. L., Vaeth, M., Mabuchi, K., «Studies of the mortality of atomic bomb survivors, Report 12, part I. Cancer: 1950–1990. 1996», en Radiat Res., 178(2), 2012, pp. AV61–AV87.

[23]. Brenner, D., Elliston, C., Hall, E., Berdon, W. E., «Estimated risks of radiation-induced fatal cancer from pediatric CT», en AJR Am J Roentgenol., 176(2), 2001, pp. 289–296.

[24]. Rogers, L. F., «Taking care of children: check out the parameters used for helical CT», en AJR Am J Roentgenol., 176(2), 2001, p. 287.

[25]. Berrington de Gonzingt, A., Mahesh, M., Kim, K. P., et al., «Projected cancer risks from computed tomographic scans performed in the United States in 2007», en Arch Intern Med., 169(22), 2009, pp. 2071–2077.

[26]. Institute of Medicine, Breast cancer and the environment: a life course approach, The National Academies Press, Washington, D. C., 2012.

[27]. Picano, E., «Informed consent and communication of risk from radiological and nuclear medicine examinations: how to escape from a communication inferno», en BMJ, 329(7470), 2004, pp. 849–851.

[28]. Schmidt, C. W., «CT scans: balancing health risks and medical benefits», en Environ Health Perspect., 120(3), 2012, pp. A118–A121.

[29]. Pearce, M. S., Salotti, J. A., Little, M. P., et al., «Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study», en Lancet, 380(9840), 2012, pp. 499–505.

[30]. Limaye, M. R., Severance, H., «Pandora’s boxes: questions unleashed in airport scanner debate», en J Am Osteopath Assoc., 111(2), 2011, pp. 87–88, 119.

[31]. Friedberg, W., Copeland, K., Duke, F. E., O’Brien, K., Darden, E. B., «Radiation exposure during air travel: guidance provided by the Federal Aviation Administration for air carrier crews», en Health Phys., 79(5), 2000, pp. 591–595.

[32]. Yong, L. C., Petersen, M. R., Sigurdson, A. J., Sampson, L. A., Ward, E. M., «High dietary antioxidant intakes are associated with decreased chromosome translocation frequency in airline pilots», en Am J Clin Nutr., 90(5), 2009, pp. 1402–1410.

[33]. Podmore, I. D., Griffiths, H. R., Herbert, K. E., Mistry, N., Mistry, P., Lunec, J., «Vitamin C exhibits pro-oxidant properties», en Nature, 392(6676), 1998, p. 559.

[34]. Yong, L. C., Petersen, M. R., Sigurdson, A. J., Sampson, L. A., Ward, E. M., «High dietary antioxidant intakes are associated with decreased chromosome translocation frequency in airline pilots», en Am J Clin Nutr., 90(5), 2009, pp. 1402–1410.

[35]. Yong, L. C., Petersen, M. R., Sigurdson, A. J., Sampson, L. A., Ward, E. M., «High dietary antioxidant intakes are associated with decreased chromosome translocation frequency in airline pilots», en Am J Clin Nutr., 90(5), 2009, pp. 1402–1410.

[36]. Sauvaget, C., Kasagi, F., Waldren, C. A., «Dietary factors and cancer mortality among atomic-bomb survivors», en Mutat Res., 551(1–2), 2004, pp. 145–152.

[37]. Kordysh, E. A., Emerit, I., Goldsmith, J. R., et al., «Dietary and clastogenic factors in children who immigrated to Israel from regions contaminated by the Chernobyl accident», en Arch Environ Health, 56(4), 2001, pp. 320–326.

[38]. Langham, W. H., Bassett, H., Harris, P. S., Carter, R. E., «Distribution and excretion of plutonium administered intravenously to man. Los Alamos: Los Alamos Scientific Laboratory, LAB1151», en Health Physics., 38, 1980, p. 1,031B1,060.

[39]. Loscialpo, M. J., «Nontherapeutic human research experiments on institutionalized mentally retarded children: civil rights and remedies», en 23 New Eng J on Crim & Civ Confinement., 139, 1997, pp. 143–145.

[40]. Assistant to the Secretary of Defense for Nuclear and Chemical and Biological Defense Programs, Department of Defense, «Report on search for human radiation experiment records 1944–1994», en <http://www.defense.gov/pubs/dod hre/>, junio de 1997. Último acceso 12 de marzo de 2015.

[41]. Kouvaris, J. R., Kouloulias, V. E., Vlahos, L. J., «Amifostine: the first selective-target and broadspectrum radioprotector», en Oncologist, 12(6), 2007, pp. 738–747.

[42]. Rao, B. N., Archana, P. R., Aithal, B. K., Rao, B. S. S., «Protective effect of zingerone, a dietary compound against radiation induced genetic damage and apoptosis in human lymphocytes», en Eur J Pharmacol., 657(1–3), 2011, pp. 59–66.

[43]. Arora, R., Gupta, D., Chawla, R., et al., «Radioprotection by plant products: present status and future prospects», en Phytother Res., 19(1), 2005, p. 1–22.

[44]. Malekirad, A. A., Ranjbar, A., Rahzani, K., et al., «Oxidative stress in radiology staff», en Environ Toxicol Pharmacol., 20(1), 2005, pp. 215–218.

[45]. Zeraatpishe, A., Oryan, S., Bagheri, M. H., et al., «Effects of Melissa officinalis L. on oxidative status and DNA damage in subjects exposed to long-term low-dose ionizing radiation», en Toxicol Ind Health, 27(3), 2011, pp. 205–212.

[46]. Zhong, W., Maradit-Kremers, H., St. Sauver, J. L., et al., «Age and sex patterns of drug prescribing in a defined American population», en Mayo Clin Proc., 88(7), 2013, pp. 697–707.

[47]. Lindsley, C. W., «The top prescription drugs of 2011 in the United States: antipsychotics and antidepressants once again lead CNS therapeutics», en ACS Chem Neurosci., 3(8), 2012, pp. 630–631.

[48]. Centers for Disease Control National Center for Health Statistics, «National Ambulatory Medical Care Survey: 2010 Summary Tables», en <http://www.cdc.gov/nchs/data/ahcd/namcs_summary/2010_namcs_web_tables.pdf>, 2010. Último acceso 12 de marzo de 2015.

[49]. Hudson, B., Zarifeh, A., Young, L., Wells, J. E., «Patients’ expectations of screening and preventive treatments», en Ann Fam Med., 10(6), 2012, pp. 495–502.

[50]. Lytsy, P., Westerling, R., «Patient expectations on lipid-lowering drugs», en Patient Educ Couns., 67(1–2), 2007, pp. 143–150.

[51]. Trewby, P. N., Reddy, A. V., Trewby, C. S., Ashton, V. J., Brennan, G., Inglis, J., «Are preventive drugs preventive enough? A study of patients’ expectation of benefit from preventive drugs», en Clin Med., 2(6), 2002, pp. 527–533.

[52]. Trewby, P. N., Reddy, A. V., Trewby, C. S., Ashton, V. J., Brennan, G., Inglis, J., «Are preventive drugs preventive enough? A study of patients’ expectation of benefit from preventive drugs», en Clin Med., 2(6), 2002, pp. 527–533.

[53]. Trewby, P. N., Reddy, A. V., Trewby, C. S., Ashton, V. J., Brennan, G., Inglis, J., «Are preventive drugs preventive enough? A study of patients’ expectation of benefit from preventive drugs», en Clin Med., 2(6), 2002, pp. 527–533.

[54]. Trewby, P. N., Reddy, A. V., Trewby, C. S., Ashton, V. J., Brennan, G., Inglis, J., «Are preventive drugs preventive enough? A study of patients’ expectation of benefit from preventive drugs», en Clin Med., 2(6), 2002, pp. 527–533.

[55]. Esselstyn, C. B. Jr., Gendy, G., Doyle, J., Golubic, M., Roizen, M. F., «A way to reverse CAD?», en J Fam Pract., 63(7), 2014, pp. 356–364b.

[56]. Esselstyn, C. B. Jr., Gendy, G., Doyle, J., Golubic, M., Roizen, M. F., «A way to reverse CAD?», en J Fam Pract., 63(7), 2014, pp. 356–364b.

[57]. Duthie, G. G., Wood, A. D., «Natural salicylates: foods, functions and disease prevention», en Food Funct., 2(9), 2011, pp. 515–520.

[58]. Fuster, V., Sweeny, J. M., «Aspirin: a historical and contemporary therapeutic overview», en Circulation, 123(7), 2011, pp. 768–778.

[59]. Pasche, B., Wang, M., Pennison, M., Jimenez, H., «Prevention and treatment of cancer with aspirin: where do we stand?», en Semin Oncol., 41(3), 2014, pp. 397–401.

[60]. Karnezis, T., Shayan, R., Fox, S., Achen, M. G., Stacker, S. A., «The connection between lymphangiogenic signalling and prostaglandin biology: a missing link in the metastatic pathway», en Oncotarget, 3(8), 2012, pp. 893–906.

[61]. Macdonald, S., «Aspirin use to be banned in under 16 year olds», en BMJ, 325(7371), 2002, p. 988.

[62]. Siller-Matula, J. M., «Hemorrhagic complications associated with aspirin: an underestimated hazard in clinical practice?», en JAMA, 307(21), 2012, pp. 2318–2320.

[63]. Sutcliffe, P., Connock, M., Gurung, T., et al., «Aspirin in primary prevention of cardiovascular disease and cancer: a systematic review of the balance of evidence from reviews of randomized trials», en PLoS ONE, 8(12), 2013, p. e81970.

[64]. Thun, M. J., Jacobs, E. J., Patrono, C., «The role of aspirin in cancer prevention», en Nat Rev Clin Oncol., 9(5), 2012, pp. 259–267.

[65]. McCarty, M. F., «Minimizing the cancer-promotional activity of cox-2 as a central strategy in cancer prevention», en Med Hypotheses, 78(1), 2012, pp. 45–57.

[66]. Duthie, G. G., Wood, A. D., «Natural salicylates: foods, functions and disease prevention», en Food Funct., 2(9), 2011, pp. 515–520.

[67]. Paterson, J. R., Blacklock, C., Campbell, G., Wiles, D., Lawrence, J. R., «The identification of salicylates as normal constituents of serum: a link between diet and health?», en J Clin Pathol., 51(7), 1998, pp. 502–505.

[68]. Rinelli, S., Spadafranca, A., Fiorillo, G., Cocucci, M., Bertoli, S., Battezzati, A., «Circulating salicylic acid and metabolic and infl ammatory responses after fruit ingestion», en Plant Foods Hum Nutr., 67(1), 2012, pp. 100–104.

[69]. Blacklock, C. J., Lawrence, J. R., Wiles, D., et al., «Salicylic acid in the serum of subjects not taking aspirin. Comparison of salicylic acid concentrations in the serum of vegetarians, non-vegetarians, and patients taking low dose aspirin», en J Clin Pathol., 54(7), 2001, pp. 553–555.

[70]. Knutsen, S. F., «Lifestyle and the use of health services», en Am J Clin Nutr., 59(5 Suppl), 1994, pp. 1171S–1175S.

[71]. McCarty, M. F., «Dietary nitrate and reductive polyphenols may potentiate the vascular benefit and alleviate the ulcerative risk of low-dose aspirin», en Med Hypotheses, 80(2), 2013, pp. 186–190.

[72]. Willcox, B. J., Willcox, D. C., Todoriki, H., et al., «Caloric restriction, the traditional Okinawan diet, and healthy aging: the diet of the world’s longest-lived people and its potential impact on morbidity and life span», en Ann N Y Acad Sci., 1114, 2007, pp. 434–455.

[73]. McCarty, M. F., «Minimizing the cancer-promotional activity of cox-2 as a central strategy in cancer prevention», en Med Hypotheses, 78(1), 2012, pp. 45–57.

[74]. Paterson, J. R., Srivastava, R., Baxter, G. J., Graham, A. B., Lawrence, J. R., «Salicylic acid content of spices and its implications», en J Agric Food Chem., 54(8), 2006, pp. 2891–2896.

[75]. Paterson, J. R., Srivastava, R., Baxter, G. J., Graham, A. B., Lawrence, J. R., «Salicylic acid content of spices and its implications», en J Agric Food Chem., 54(8), 2006, pp. 2891–2896.

[76]. Pasche, B., Wang, M., Pennison, M., Jimenez, H., «Prevention and treatment of cancer with aspirin: where do we stand?», en Semin Oncol., 41(3), 2014, pp. 397–401.

[77]. Paterson, J. R., Srivastava, R., Baxter, G. J., Graham, A. B., Lawrence, J. R., «Salicylic acid content of spices and its implications», en J Agric Food Chem., 54(8), 2006, pp. 2891–2896.

[78]. Baxter, G. J., Graham, A. B., Lawrence, J. R., Wiles, D., Paterson, J. R., «Salicylic acid in soups prepared from organically and non-organically grown vegetables», en Eur J Nutr., 40(6), 2001, pp. 289–292.

[79]. Scheier, L., «Salicylic acid: one more reason to eat your fruits and vegetables», en J Am Diet Assoc., 101(12), 2001, pp. 1406–1408.

[80]. Duthie, G. G., Wood, A. D., «Natural salicylates: foods, functions and disease prevention», en Food Funct., 2(9), 2011, pp. 515–520.

[81]. Seeff, L. C., Richards, T. B., Shapiro, J. A., et al., «How many endoscopies are performed for colorectal cancer screening? Results from CDC’s survey of endoscopic capacity», en Gastroenterology, 127(6), 2004, pp. 1670–1677.

[82]. McLachlan, S. A., Clements, A., Austoker, J., «Patients’ experiences and reported barriers to colonoscopy in the screening context—a systematic review of the literature», en Patient Educ Couns., 86(2), 2012, pp. 137–146.

[83]. Lobel, E. Z., Korelitz, B. I., «Postendoscopy syndrome: “the doctor never talked to me”», en J Clin Gastroenterol., 33(5), 2001, pp. 353–354.

[84]. McLachlan, S. A., Clements, A., Austoker, J., «Patients’ experiences and reported barriers to colonoscopy in the screening context—a systematic review of the literature», en Patient Educ Couns., 86(2), 2012, pp. 137–146.

[85]. Whitlock, E. P., Lin, J. S., Liles, E., Beil, T. L., Fu, R., «Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force», en Ann Intern Med., 149(9), 2008, pp. 638–658.

[86]. Manner, H., Plum, N., Pech, O., Ell, C., Enderle, M. D., «Colon explosion during argon plasma coagulation», en Gastrointest Endosc., 67(7), 2008, pp. 1123–1127.

[87]. Ko, C. W., Dominitz, J. A., «Complications of colonoscopy: magnitude and management», en Gastrointest Endosc Clin N Am., 20(4), 2010, pp. 659–671.

[88]. Whitlock, E. P., Lin, J. S., Liles, E., Beil, T. L., Fu, R., «Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force», en Ann Intern Med., 149(9), 2008, pp. 638–658.

[89]. Van Hees, F., Habbema, J. D., Meester, R. G., Lansdorp-Vogelaar, I., Van Ballegooijen, M., Zauber, A. G., «Should colorectal cancer screening be considered in el derly persons without previous screening? A cost-effectiveness analysis», en Ann Intern Med., 160(11), 2014, pp. 750–759.

[90]. Whitlock, E. P., Lin, J. S., Liles, E., Beil, T. L., Fu, R., «Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force», en Ann Intern Med., 149(9), 2008, pp. 638–658.

[91]. Brenner, H., Stock, C., Hoffmeister, M., «Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies», en BMJ, 348, 2014, p. g2467.

[92]. Swan, H., Siddiqui, A. A., Myers, R. E., «International colorectal cancer screening programs: population contact strategies, testing methods and screening rates», en Pract Gastroenter., 36(8), 2012, pp. 20–29.

[93]. Ling, B. S., Trauth, J. M., Fine, M. J., et al., «Informed decision-making and colorectal cancer screening: is it occurring in primary care?», en Med Care, 46(9 Suppl 1), 2008, pp. S23–S29.

[94]. Ling, B. S., Trauth, J. M., Fine, M. J., et al., «Informed decision-making and colorectal cancer screening: is it occurring in primary care?», en Med Care, 46(9 Suppl 1), 2008, pp. S23–S29.

[95]. Brett, A. S., «Flexible sigmoidoscopy for colorectal cancer screening: more evidence, persistent ironies», en JAMA, 312(6), 2014, pp. 601–602.

[96]. Yabroff, K. R., Klabunde, C. N., Yuan, G., et al., «Are physicians’ recommendations for colorectal cancer screening guideline-consistent?», en J Gen Intern Med., 26(2), 2011, pp. 177–184.

[97]. Swan, H., Siddiqui, A. A., Myers, R. E., «International colorectal cancer screening programs: population contact strategies, testing methods and screening rates», en Pract Gastroenter., 36(8), 2012, pp. 20–29.

[98]. Swan, H., Siddiqui, A. A., Myers, R. E., «International colorectal cancer screening programs: population contact strategies, testing methods and screening rates», en Pract Gastroenter., 36(8), 2012, pp. 20–29.

[99]. Butterfield, S., «Changes coming for colon cancer screening», en ACP Internist., 34(7), 2014, pp. 10–11.

[100]. Rosenthal, E., «The $2.7 trillion medical bill: colonoscopies explain why U.S. leads the world in health expenditures», en New York Times, <http://www.nytimes.com/2013/06/02/health/colonoscopies-explain-why-us-leads-the-world-in-health-expenditures.html>, 1 de junio de 2013. Último acceso 12 de marzo de 2015.

[101]. Whoriskey, P., Keating, D., «How a secretive panel uses data that distorts doctors’ pay», en Washington Post, <http://www.washingtonpost.com/business/economy/how-a-secretive-panel-uses-data-that-distorts-doctors-pay/2013/07/20/ee134e3a-eda8-11e2-9008-61e94a7ea20d_story.html>, 20 de julio de 2013. Último acceso 12 de marzo de 2015.

[102]. US Government Accountability Office, «Medicare: action needed to address higher use of anatomic pathology services by providers who self-refer. GAO-13-445», en <http://www.gao.gov/products/GAO-13-445>, 24 de junio de 2013. Último acceso 12 de marzo de 2015.

[103]. Spirling, L. I., Daniels, I. R., «Botanical perspectives on health peppermint: more than just an afterdinner mint», en J R Soc Promot Health, 121(1), 2001, pp. 62–63.

[104]. Amato, A., Liotta, R., Mulè, F., «Effects of menthol on circular smooth muscle of human colon: analysis of the mechanism of action», en Eur J Pharmacol., 740, 2014, pp. 295–301.

[105]. Leicester, R. J., Hunt, R. H., «Peppermint oil to reduce colonic spasm during endoscopy», en Lancet, 2(8305), 1982, p. 989.

[106]. Asao, T., Mochiki, E., Suzuki, H., et al., «An easy method for the intraluminal administration of peppermint oil before colonoscopy and its effectiveness in reducing colonic spasm», en Gastrointest Endosc., 53(2), 2001, pp. 172–177.

[107]. Shavakhi, A., Ardestani, S. K., Taki, M., Goli, M., Keshteli, A. H., «Premedication with peppermint oil capsules in colonoscopy: a double blind placebo-controlled randomized trial study», en Acta Gastroenterol Belg., 75(3), 2012, pp. 349–353.

[108]. Stange, K. C., «Barbara Starfield: passage of the pathfinder of primary care», en Ann Fam Med., 9(4), 2011, pp. 292–296.

[109]. Starfield, B., «Is US health really the best in the world?», en JAMA, 284(4), 2000, pp. 483–485.

[110]. Rappoport, J., «An exclusive interview with Dr. Barbara Starfield: medically caused death in America», en Jon Rappoport’s Blog, <https://jonrappoport.word press.com/2009/12/09/an-exclusive-interview-with-dr-barbara-starfield-medica lly-caused-death-in-america/>, 9 de diciembre de 2009. Último acceso 12 de marzo de 2015.

[111]. Millenson, M. L., «The silence», en Health Aff. (Millwood)., 22(2), 2003, pp. 103–112.

[112]. Holtzman, N. A., «Chronicle of an unforetold death», en Arch Intern Med., 172(15), 2012, pp. 1174–1177.

[113]. Anand, S. S., Islam, S., Rosengren, A., et al., «Risk factors for myocardial infarction in women and men: insights from the INTERHEART study», en Eur Heart J., 29(7), 2008, pp. 932–940.